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EXECUTIVE SUMMARY 
Background 
There has been a decade of MMR vaccine uptake which is below the threshold for 
herd immunity for measles and large numbers of children are unprotected. The 
number of measles cases in England is now rising (DH, 2008). The Department of 
Health has issued a letter about the urgent action needed to reduce the risk of a 
measles epidemic. PCTs are following DH guidance in conducting MMR catch up 
programmes to increase uptake to 95% to gain herd immunity for the population, as 
well as increasing the overall immunisation coverage. 
 
Objectives  
We carried out a rapid review of published studies to assess the evidence of the 
effectiveness of interventions to promote uptake of immunisation, with a particular 
emphasis on MMR. We also included studies which assessed healthcare 
professionals’ issues relating to immunisation and studies which examined parents’ 
concerns and issues that influenced decision making associated with vaccination. 
 
Search Strategy 
We searched electronic databases MEDLINE (1966 – 2009), CINAHL (1982 – 2009), 
DARE, EMBASE (1980 – 2009), NHS EED, CENTRAL, HTA, and the CRDS, 
PsycINFO (1985 – 2009). Results from reviews, published papers, and citations were 
used. 
 
Selection criteria 
Eligible studies were randomised trials, economic evaluations, ecological studies, 
surveys, interviews and focus groups, published by 2009. 
 
Data collection and analysis  
We identified 1313 articles possibly satisfying our search criteria and included 80 in 
the review. 
 
Main results 
This review has identified from published research, associations with groups where 
coverage for MMR is likely to be lower, children are more likely to be partially 
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immunised, have a delay in immunisation, receive a single vaccine or are unlikely to 
immunise at all. The review has also identified interventions which may be effective 
in a primary care context, as well as some interventions which are likely to be 
ineffective. The review has identified some of the concerns and problems among 
primary care practitioners, specifically GPs, health visitors and practice nurses. 
Furthermore, the review has found information about why parents have concerns 
about immunising their infants and some of the reasons they choose not to 
immunise. 
 
Conclusions 
Strategies can be introduced in primary care to increase the uptake of immunisation, 
particularly MMR. These include training, audit and feedback for health care 
professionals and reminder systems for parents. 
 
Recommendations 
Our recommendations are therefore as follows: 
 
1. Education for health care professionals should be a priority to address parental 
concerns, 
2. Practices should use a strategic approach to maximise uptake of immunisations,  
3. Practices should accurately record immunisation uptake, including single 
antigens, and use computers for identifying parents who need to be reminded,  
4. Practice should use a postal reminder, followed by a telephone call to parents, 
5. Practices should perform regular audit with feedback to all health care 
professionals involved in immunisations,  
6. Practices should consider collaborating with schools to plan ‘mop-up’ vaccination 
days. 
7. Practices should consider initiating interventions with regard to looked after 
children and refugees and immigrants. 
 
We strongly recommend that interventions which are newly introduced should be 
evaluated, ideally using a mixed methods approach, with a randomised controlled 
trial and qualitative evaluation, to capture evidence of an uptake of immunisation 
along with the perspectives of parents and health care practitioners.
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BACKGROUND 
Vaccines work by stimulating the immune system to develop antibodies to combat 
infections, without the recipient suffering from the disease itself. The aim of 
vaccination is to offer protection to the recipient, who therefore becomes less likely to 
infect others, reducing the risk to others who have not been vaccinated. 
 
This concept of population or herd immunity means that if there is a high level of 
immunity because a large enough number of a given population have been 
immunised, the remaining unimmunised members of the population will receive some 
protection from infection. This is because the antibodies in the immunised individuals 
will inactivate the virus and prevent it from being passed on to unimmunised people. 
The levels of uptake required for herd immunity varies for different diseases and 
depends on how contagious the disease is and on the conditions which allow it to 
spread. For a disease which is highly contagious and where the average age of 
infection is younger, the higher the proportion of people required to be immune, 
before the non-immune people can be protected by herd immunity. It is possible to 
calculate the proportion of people who should be vaccinated to prevent the disease 
from spreading. For example, the herd immunity threshold for measles is 92% - 95%, 
for rubella is 83% - 90%, and for polio is 80% - 86% (WHO, 2009). In this way people 
who cannot be immunised, because they are immunocompromised, for example due 
to cancer treatment, organ transplantation or have a weak immune system, also 
receive some benefit (Salisbury et al, 2006). 
 
Where there are high levels of population immunity from high coverage, diseases 
such as diphtheria can be eliminated, so long as high vaccination coverage is 
maintained. In 1980 because of vaccination, smallpox was declared eradicated. In a 
similar way the World Health Organization is aiming to eradicate poliomyelitis. 
 
In 1940, before the introduction of vaccination programmes: 409,281 children 
contacted measles, 53,607 contacted whooping cough, and 46,281 contacted 
diphtheria. In 1989, there were 24,570 cases of rubella, and 20,713 cases of mumps 
(Yarwood et al, 2005). 
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The UK immunisation programme 
The overall aim of the routine childhood immunisation programme is to achieve and 
maintain high vaccination coverage to protect all children against the following 
preventable childhood infections: Diphtheria, tetanus, pertussis (whooping cough), 
Haemophilus influenzae type b, polio, meningococcal serogroup C, measles, mumps, 
rubella and pneumococcal. 
 
In England there have been a series of changes to the immunisation programme. 
MMR vaccine was introduced in 1988, Hib was introduced in 1992, combined DTP-
Hib in 1996, MenC in 1999, and DtaP pre-school booster was introduced in 2001. 
Two doses of the MMR vaccine are recommended to ensure immunity, as about 15% 
of vaccinated children fail to develop immunity from the first dose (WHO, 2008). 
 
The schedule for routine childhood immunisations in the UK is shown in Table 1. 
 
Table 1: Schedule for the routine childhood immunisation programme 2009 
(Source: NHS Immunisation Service, 2009) 
When to 
immunise  
Diseases protected against  Vaccine given  
Two months old  Diphtheria, tetanus, pertussis (whooping 
cough), polio and Haemophilus influenzae 
type b (Hib) 
Pneumococcal infection  
DTaP/IPV/Hib  
+ Pneumococcal 
conjugate 
vaccine, (PCV)  
Three months 
old  
Diphtheria, tetanus, pertussis, polio and 
Haemophilus influenzae type b (Hib) 
Meningitis C  
DTaP/IPV/Hib  
+ MenC  
Four months old  Diphtheria, tetanus, pertussis, polio and 
Haemophilus influenzae type b (Hib) 
Meningitis C 
Pneumococcal infection  
DTaP/IPV/Hib  
+ MenC + PCV  
Around 12 
months  
Haemophilus influenza type b (Hib) 
Meningitis C  
Hib/MenC  
Around 13 
months old  
Measles, mumps and rubella 
Pneumococcal infection  
MMR 
+ PCV  
Three years and 
four months or 
soon after  
Diphtheria, tetanus, pertussis and polio 
Measles, mumps and rubella  
DTaP/IPV or 
dTaP/IPV 
+MMR  
Girls aged 12 to 
13 years  
Cervical cancer caused by human 
papillomavirus 
types 16 and 18. 
HPV 
13 to 18 years 
old  
Diphtheria, tetanus, polio  Td/IPV  
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Uptake of first immunisation 
Vaccine uptake is generally high for first immunisation. Table 2 shows the variation in 
uptake of first immunisation by PCT in Yorkshire and The Humber, compared with 
the whole of England 2008. 
 
Table 2: Percentage of children immunised by their 1st birthday, by 
Government Office Region and PCT, October - December 2008 (Source: Health 
Protection Agency, 2009) 
Government Office 
Region and PCT 
Number 
of 
children 
DTaP/IPV
/Hib 
% 
MenC2 
% 
PCV2 
% 
Sheffield PCT 1699 90.1 89.4 88.9 
Leeds PCT 2256 91.7 91.3 91.1 
Doncaster PCT 965 92.7 92.5 93.0 
North Yorkshire & 
York PCT 
1694 93.2 92.6 91.1 
Yorkshire & the 
Humber 
15957 93.4 93.0 92.7 
Bradford & Airedale 
PCT 
2121 93.7 92.7 92.5 
Rotherham PCT 786 93.8 93.4 93.5 
Kirklees PCT 1391 93.9 94.1 94.0 
Hull PCT 914 94.0 93.5 94.1 
Calderdale PCT 679 94.0 94.0 94.1 
North Lincolnshire 
PCT 
467 94.0 94.4 94.0 
Wakefield District PCT 1012 94.4 94.0 93.7 
North East 
Lincolnshire PCT 
501 94.6 94.8 94.6 
Barnsley PCT 715 96.8 96.8 96.8 
East Riding of 
Yorkshire PCT 
757 97.6 97.4 97.4 
England  164228 91.6 91.0 91.1 
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Measles 
Measles is one of the most highly communicable infectious diseases and one death 
will occur in every 5000 cases in the UK (Salisbury et al, 2006). About 100 deaths 
per year occurred before 1968 when the measles vaccine was introduced (Salisbury 
et al, 2006). Measles results in otitis media in 7-9% cases, pneumonia in up to 6% of 
cases, diarrhoea in 8%, and convulsions in <1% of cases (Salisbury et al, 2006). 
Encephalitis is a less frequently occurring complication. Children less than one year 
and teenagers and adults are more likely to die from measles than children aged one 
to nine years. Children who are more poorly nourished, chronically ill or 
immunosuppressed are also more likely to suffer a fatal measles infection. 
 
The WHO and UNICEF are collaborating to reduce global measles deaths by 90% by 
2010. The strategy includes: 
1. Strong routine immunization: for children by their first birthday. 
2. A 'second opportunity' for measles immunization through mass vaccination 
campaigns, to ensure that all children receive at least one dose. 
3. Effective surveillance in all countries to quickly recognize and respond to measles 
outbreaks. 
4. Better treatment of measles cases, to include vitamin A supplements, antibiotics if 
needed, and supportive care that prevents complications. 
 
Uptake of MMR 
Until the late 1980’s coverage remained low so measles continued to be a major 
cause of morbidity and mortality, until the measles, mumps and rubella vaccine was 
introduced in 1988. In the early 1990’s coverage levels of 90% or more were 
associated with very low levels of notification of measles (Salisbury et al, 2006). In 
the UK in 1994-1995, a mass immunisation campaign with a measles and rubella 
vaccine (MR) was aimed at children aged 5-16 years. Immunisation uptake for MMR 
peaked in 1995 at 92% for two-year olds (Pearce et al, 2008). 
 
In 1998 a paper was published by Wakefield and others in the Lancet proposing a 
link between MMR and Crohn’s disease, and then there was a purported increased 
risk of autism in children vaccinated with MMR compared with unvaccinated children. 
A retraction of the interpretation of the data was published in The Lancet in 2004. A 
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systematic review of 31 articles has concluded that exposure to MMR was unlikely to 
be associated with Crohn’s disease, ulcerative colitis, autism or aseptic meningitis 
(Jefferson et al, 2003; Demicheli et al, 2005). The DH now says there now 
overwhelming evidence that MMR is not associated with autism (DH, 2009). 
 
The media were found to have a powerful effect and parents were strongly influenced 
by the perceived risk that a vaccine carries (Yarwood et al, 2005). An association 
with the adverse effects of a local evening newspaper campaign which began in July 
1997 in Wales, was observed when the uptake of MMR declined in the distribution 
area of the newspaper by 13.6% (95% CI, -16.2% to -10.9%) compared with the rest 
of Wales, which saw a 2.4% reduction in uptake (95% CI, -5.5% to -1.4%) (Mason & 
Donnelly, 2000).  
 
Uptake of MMR fell by 10% from 92% in England in 1995/6 to 82% in 2002/3, which 
is below the herd immunity threshold for measles (92% - 95%) with regional 
variations, for example, 58% in Kensington and Chelsea and 92% in West Cumbria 
(POST, 2004). Between January and March 2008, in the UK, MMR uptake for 
children reaching 24 months of age was 84.1% vaccine coverage (HPA, 2008). 
 
Measles epidemics arise from a combination of factors, such as the age structure of 
a population, social and spatial arrangement and the season of transmission. A most 
important predictive factor is the reproductive number, which is proportional to the 
fraction of the population that is not immunised and depends on the average size of 
outbreaks. As the reproductive number approaches 1, this indicates that a large 
measles outbreak is increasingly likely (Jansen 2003). The estimated reproductive 
number was 0.47 for 1995 – 1998 and was 0.82 for 1999 – 2002 (Jansen 2003). As 
the proportion of unvaccinated individuals increases, a further increase in the 
reproductive number will possibly lead to endemic measles and the concomitant 
mortality (Jansen 2003). In this way parents increase the risk of exposure to measles 
by choosing not to have their infants immunised (Jansen 2003). There have been 
local outbreaks of measles where MMR uptake is low (POST, 2004). 
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Before 1998, MMR uptake was lower among children born to single parents, and 
those in larger families in more deprived socially areas (Pearce et al, 2008). Since 
1998, uptake has declined among more affluent areas (Pearce et al, 2008). 
 
Some parents have chosen to use single vaccines for measles, mumps or rubella or 
use no vaccine at all (Wright et al, 2005). These separate vaccines are not available 
through the NHS and their uptake through the private sector is not recorded in 
routinely collected statistics (Wright et al, 2005). At least 5.2% of three year old 
children in the Millennium Cohort study had received at least one of the single 
antigen vaccines (Pearce et al, 2009) whilst 17.5% of all mothers in a study in 
Brighton reported that they had chosen single mumps measles and rubella antigen 
vaccines, available privately or from overseas (Cassell, 2006). Children in England 
would require 21 single antigen injections rather than seven combined injections by 
the age of 15 months (Tickner, 2006). Only a quarter of children might receive all 
three measles, mumps and rubella vaccines (Casiday, 2006) indicating that the 
combined administration schedule might prove more efficient, easier to remember 
and less distressing for infants and their mothers (Tickner, 2006). 
 
Measles outbreaks 
The impact of disproportionate adverse publicity on the uptake of the MMR 
vaccination programme has been well described (Ramsay et al, 2002) and the drop 
in the uptake of vaccine has been associated with a number of measles outbreaks in 
England and Wales since 1998 (Jansen 2003). In the North East of England up to 
May 2009, 53 cases of measles had been confirmed and more than 100 suspected 
cases were being investigated. This number is greater than the total number of cases 
reported for the whole of the previous year in the North East (HPA, 2009). Table 3 
shows the number of confirmed cases of measles in England and Wales in 2008 and 
Figure 1 illustrates graphically the increase in the number of cases over time from 
1995. 
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Table 3: Confirmed cases of measles by region, 2008 (Source: Health 
Protection Agency, 2009) 
Age 
group 
NE NW Y&H EM WM EE Lon SE SW W NK Total 
< 1y 2 10 3 4 8 7 59 16 3 0 0 112 
1-4y 4 59 20 17 25 18 154 29 12 7 0 345 
5-9y 2 46 13 8 30 18 140 32 7 8 0 304 
10-14y 7 32 6 3 17 19 124 19 5 11 0 243 
15-19y 1 9 1 8 9 14 74 9 6 6 0 137 
20-24y 0 8 0 3 4 6 48 4 0 4 1 78 
25-29y 1 5 2 3 7 2 21 4 2 1 0 48 
30-34y 0 5 3 1 5 6 21 7 2 2 0 52 
>=35y 0 5 2 1 8 0 23 8 4 0 0 51 
Total 17 179 50 48 113 90 664 128 41 39 1 1370 
Note: Lon=London, Y&H=Yorkshire & Humberside, EE=East of England EM=East Midlands, WM=West Midlands, 
W=Wales. 
 
Figure 1: Notifications (confirmed cases) 1995-2009 by quarter (Health 
protection Agency, 2009) 
 
 8 
For the Yorkshire and Humberside region, in 2008 cases of measles comprised 3.6% 
of all cases in England and Wales. In the first quarter of 2009, the 15 cases 
confirmed in Yorkshire and Humberside comprised 4.3% of all confirmed measles 
cases in England and Wales. 
 
Table 4: Number of laboratory confirmed measles cases by age group and 
regional health authorities with onset dates in January to March 2009: England 
and Wales (Source: HPA, 2009) 
Age 
group 
NE NW Y&H EM WM EE Lon SE SW W NK Total 
< 1y 0 9 0 1 7 0 6 5 0 0 0 28 
1-4y 0 12 2 6 11 9 23 29 4 3 0 99 
5-9y 1 2 5 1 11 0 26 31 1 7 0 85 
10-14y 0 5 5 0 7 1 22 23 1 5 0 69 
15-19y 0 4 1 0 4 0 10 11 0 3 0 33 
20-24y 0 3 0 0 2 0 2 6 0 0 0 13 
25-29y 0 1 0 1 1 1 1 1 0 0 0 6 
30-34y 0 0 1 0 2 2 4 1 0 0 0 10 
>=35y 0 2 1 1 0 0 2 2 1 0 0 9 
Total 1 38 15 10 45 13 96 109 7 18 0 352 
Note: Lon=London, Y&H=Yorkshire & Humberside, EE=East of England EM=East Midlands, WM=West Midlands, 
W=Wales. 
 
As well as an increase in the number of confirmed cases of measles, Table 5 
illustrates the increase in the number of confirmed cases of mumps in England and 
Wales. 
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Table 5: All laboratory confirmed cases of measles, mumps & rubella, England 
and Wales, 1996 - 2008 (Source: HPA, 2009) 
Year  Measles Mumps Rubella 
1996  112 94 3922 
1997  177 182 117 
1998  56 121 119 
1999  92 373 162 
2000  100 730 62 
2001 70 784 45 
2002 319 500 64 
2003 437 1541 16 
2004 188 8129 14 
2005 78 43378 29 
2006 740 4420 34 
2007 990 1476 35 
2008 1370 2440 27 
 
Mothers’ attitudes 
A series of surveys began in 1991 to track mothers’ knowledge, attitudes and 
experiences of immunisation (Yarwood et al, 2005; Smith et al, 2007) as well as 
measure their recall and interpretation of advertising and immunisation materials. 
These surveys have captured the evolving attitudes since the height of the MMR 
controversy and found that the MMR vaccine remains the main vaccination issue for 
parents, but the proportion of parents who believe the MMR risk is greater than the 
disease has fallen from 24% in 2002 to 14% in 2006 (Smith et al, 2007). Also the 
proportion who have said the MMR was completely safe has risen from 60% in 2002 
to 74% in 2006 (Smith et al, 2007). However, the proportion of parents who reject 
MMR has remained stable at 6%. 
 
Suboptimal uptake is not exclusive to MMR as a substantial proportion of children 
also miss their primary DTP vaccination (Ticknet et al, 2006) or do not complete the 
full course. 
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SUMMARY 
There has been a decade of MMR vaccine uptake which is below the threshold for 
herd immunity for measles and large numbers of children are unprotected. The 
number of measles cases in England is now rising (DH, 2008). The Department of 
Health has issued a letter about the urgent action needed to reduce the risk of a 
measles epidemic (DH, 2008) and PCTs are following DH guidance in conducting a 
MMR catch up programme (DH, 2008), seeking to increase MMR uptake to 95% to 
gain herd immunity for the population, as well as increasing the overall immunisation 
coverage. 
 
AIM AND OBJECTIVES 
The primary aim of this rapid review was to undertake a comprehensive literature 
review of interventions aimed at improving immunisation uptake, with a focus on 
MMR, followed by evidence based recommendations on how to improve MMR 
uptake. 
 
In addition to the main study aim, our objectives were to answer the following 
questions: 
 
What are the main issues for health care professionals in maximising immunisation 
uptake? 
 
What are the conditions associated with low uptake of immunisations? 
 
What do parents think about having their children immunised and what do they 
consider are the main barriers to having their infant immunised with MMR? 
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METHOD 
Our broad search aimed to identify all studies relevant to the study main aim and 
objectives.  
 
Types of studies 
We included comparative prospective and retrospective studies, economic 
evaluations, surveys, and qualitative studies. 
 
Participants 
Health care professionals or parents were included in the studies.  
 
Types of intervention  
We included reviews of office-based interventions and client-oriented interventions 
intended to maximise the uptake of recommended immunisations. We also included 
studies of interventions in schools and hospitals.  
 
Types of outcome measures 
Immunisations uptake and seroprevalence. 
 
Search methods for identification of studies 
We searched the Cochrane Central Register of Controlled Trials (CENTRAL) and 
MEDLINE to identify randomised controlled trials. The search terms were adapted 
and used in the other electronic databases: CINAHL, DARE, Embase, PsycLIT, NHS 
EED, HTA, the Cochrane Controlled Trials Register and the Cochrane Database of 
Systematic Reviews. Results from reviews, published papers, and citations were 
used to perform citation searches of identified studies. 
 
Data collection and analysis 
Selection criteria 
We included studies in which MMR uptake was an outcome. The broad categories 
used meant that the review covered: 
▪ Systematic reviews and reviews of primary research, 
▪ Evaluations of interventions, 
▪ Economic evaluations, 
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▪ Ecological studies, 
▪ Non-intervention studies, such as surveys of health care professionals, examining 
factors associated with immunisations uptake, 
▪ Non-intervention studies of parents examining factors associated with 
immunisations uptake, 
▪ Evidence from qualitative studies.  
 
Whilst not providing evidence of the effectiveness of a particular intervention to 
maximise immunisation uptake, further ecological studies and qualitative studies 
were included in the review to highlight the factors affecting uptake. 
 
Exclusion 
We excluded studies: which were not written in English, of immunisation uptake in 
developing countries; of interventions aiming to increase the uptake of HPV vaccine, 
hepatitis B and BCG for tuberculosis; and of interventions which were undertaken in 
prisons. Papers were not included in the review if they: were personal opinions and 
comments, described non-systematic reviews, were policy documents, or single case 
studies. 
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RESULTS 
The results from 80 studies are grouped under the following headings: 
 
1. Systematic reviews and reviews of primary research, 
2. Evaluations of interventions, 
3. Economic evaluations, 
4. Ecological studies, 
5. Non-intervention studies, such as surveys of health care professionals, examining 
factors associated with immunisations uptake, 
6. Non-intervention studies of parents examining factors associated with 
immunisations uptake, 
7. Evidence from qualitative studies.  
 
1. Evidence summary from systematic review and meta-analyses 
Data from 13 earlier reviews reporting from 1994-2005 were included (Table 1). 
These studies examined: 
▪ audit and feedback, 
▪ computers in primary care consultations, 
▪ factors affecting the uptake of immunisation, 
▪ home visiting, 
▪ immunisation delivery methods, 
▪ lay health workers, 
▪ office-based interventions, 
▪ patient reminder and recall systems, and 
▪ target payments. 
 
The conclusions from these studies were that: 
▪ Audit and feedback alone may be an effective strategy for improving immunisation 
rates but the number of well conducted studies is small and the effect is variable, 
so further well designed studies are needed to identify independent effects 
(Bordley et al, 2000). 
 
▪ Computers in primary care consultations improves immunisation rates by 8-18% 
and other preventive tasks by up to 50% (Sullivan & Mitchell, 1995). 
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▪ There is no evidence that home visiting is effective in increasing uptake of 
immunisation (Elkan et al, 2000). 
 
▪ Greater coverage rates were found:       
 for MMR with system-orientated interventions than client-orientated 
 interventions;        
 personalised mailed reminders or health care;     
 practitioner-initiated telephone calls;       
 providing feedback on practice;        
 for influenza when aimed at hospital populations;     
 for pneumococcal, client-or system-orientated hospital interventions for high-
 risk patients (Gyorkos et al, 1994). 
 
▪ For lay health workers, there were promising benefits in promoting immunisation 
uptake and improving outcomes for acute respiratory infections and malaria, when 
compared to usual care (Lewin et al, 2005). Lay support can be effective in 
increasing the uptake of vaccination, but because of differing cultural and 
sociodemographic factors, effects could be less marked when applied to British 
populations (Whittaker, 2002). 
 
▪ Office-based interventions, particularly multiple interventions deserve continued 
development and enhancement (Anderson et al, 1998). 
 
▪ Patient reminder and recall systems in primary care settings are effective in 
improving immunization rates in developed countries (Jacobson Vann et al, 2005). 
 
▪ There was strong evidence of the effectiveness of population based interventions: 
client reminder or recall, multicomponent interventions, education, reducing out-
of-pocket costs for vaccination, expanding access as part of a multi-component 
intervention, assessment and feedback for providers. There was sufficient 
evidence of the effectiveness of vaccination requirements for child care, school, 
and college attendance (in USA), interventions in Women, Infant and Children 
settings, and home visiting interventions (Briss et al, 2000). 
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▪ There was not enough evidence on whether target payment remuneration was 
associated with improvements in immunisation rates (Giuffrida et al, 1999). 
 
▪ Unintended effects associated with MMR, exposure was unlikely to be associated 
with Crohn’s disease, ulcerative colitis, autism or aseptic meningitis (Jefferson et 
al, 2003; Demicheli et al, 2005). 
 
2. Evidence summary from intervention studies 
Data from eight intervention studies reporting from 1998 – 2005 were included (Table 
2). These studies examined the effectiveness of: 
▪ A school immunisation programme, 
▪ An evidence based decision aid, 
▪ Catch-up and scheduled immunisation during hospital admission, 
▪ Health visitor or mail follow-up, 
▪ Medical education with improvement of “office systems”, 
▪ Posting the MMR – The Facts leaflet to parents, 
▪ Providing information on a) benefits and risk of immunisations, b) the role of 
emotional factors, and c) the focusing procedure, 
▪ Teddy bears wearing T-shirts displaying a website address. 
 
The conclusions from these studies were that: 
▪ A school immunisation programme was effective due: to a dedicated team, the 
active follow-up of all defaulters, a comprehensive database made available to 
schools; availability of telephone numbers; a dedicated telephone line, avoidance 
of deferral for minor illness (Joyce-Cooney et al, 2003). 
 
▪ A web based evidence based decision aid significantly improved parental 
attitudes to MMR vaccination (Wallace et al, 2005). 
 
▪ Hospital provides the opportunity for catch-up and scheduled immunisation and 
can contribute to the health care of an often disadvantaged group (Conway et al, 
1999. 
 
▪ There may be some benefit from targeting young or primiparous mothers (Morgan 
& Evans, 1998). 
 
▪ Continuing medical education combined with process improvement is effective in 
increasing rates of delivery of preventive care to children (Margolis, et al, 2004). 
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▪ More complex intervention than posting the MMR – The Facts leaflet to parents is 
required to influence the immunisation behaviour of parents (Mason & Donnelly, 
2000). 
 
▪ Providing information on a) benefits and risk of immunisations, b) the role of 
emotional factors, and c) the focusing procedure combined, as part of an 
antenatal decision aid, may increase the uptake of on time childhood 
immunisation. Further research is needed to improve understanding of the 
decision change (Wroe, et al, 2005). 
 
▪ Teddy bears wearing T-shirts displaying a website address was not effective in 
influencing MMR uptake (Porter-Jones et al, 2008). 
 
3. Evidence summary from economic evaluations 
Data from 12 economic evaluations published from 1985-2004 were included (Table 
3). These studies examined the cost-effectiveness or cost-benefit of: 
▪ DTP, Hib, polio, MMR and varicella vaccination in the USA, 
▪ Two-dose MMR vaccination in the USA, 
▪ Computer-generated reminder letters for MMR, 
▪ Parent notification or reminder systems for DTP, 
▪ Seroprevalence or re-vaccination for measles, 
▪ Routine varicella vaccination strategies for 12-18 months olds, 12- and 20-29 year 
olds in the USA,  
▪ MMR screening and vaccinating medical students in Switzerland, 
▪ Double vaccination programmes for rubella, aged 1-3 years and 6-9 years, in 
Japan. 
 
The conclusions from these studies were that: 
▪ The routine childhood vaccination schedule of DTP, Hib, polio, MMR and varicella 
in the USA is cost saving, and prevents substantial morbidity and thousands of 
deaths (Zhou et al, 2001). The two-dose MMR vaccination programme in the USA 
was highly cost-beneficial and resulted in substantial cost savings (Zhou et al, 
2004). The combined MMR vaccine programme in an epidemiological cohort 
model in the US, in 1983, was assumed to be clinically equivalent with lower costs 
than a programme using separate antigens (White et al, 1985). The two-dose 
MMR vaccination in the USA, substantially reduces the pool of susceptible 
children but the cost of seroconversion was high (Watson et al, 1996). 
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▪ A letter followed by a telephone call was the most cost-effective option to improve 
the immunisation uptake among unimmunised children (Lieu et al, 1998). The use 
of computer generated recall letters to privately insured families with 
underimmunised children of 20 months of age improved immunisation delivery 
(Lieu et al, 1997). A recall system based on an autodialer in small private 
physicians’ offices in the USA, was effective especially with a fully operational 
immunisation registry (Franzini et al, 2000). Vaccine coverage for pre-school 
children can be increased by the repeated use of automated parent notifications 
until the child is two years of age (Dini et al, 2000). 
 
▪ In the USA, varicella antibody testing and vaccination may be cost-effective for 
adults of any age who are unlikely to have immunity, or who have a greater risk of 
developing chickenpox or its complications testing followed by vaccination of 
adults aged 20-29 (Smith & Roberts, 2000). The optimum feasible varicella 
prevention strategy in Germany, is to vaccinate 15-month old children and use 
catch-up vaccination for 12-year olds (Beutels et al, 1996). 
 
▪ A targeted programme of MMR screening and vaccination for medical students in 
Switzerland was effective in increasing the immunisation rate (Germann & Matter, 
1991). 
 
▪ A double vaccination programmes in Japan, where the 1st vaccination was 
administered aged 1-3 years and the 2nd vaccination was based on the results of 
a urine test of children at primary school, aged 6-9 years, was the most effective 
strategy in improving the rate of rubella antibody detection. However, it was the 
most costly programme, but sensitive to the cost of urine antibody testing (Terada 
et al, 2000). 
 
4. Evidence summary from ecological studies 
Data from 17 studies which used existing data, for example, from Child Health 
Information Systems, Immunisation and Recall System and a cohort study and were 
published 3 earlier reviews reporting from 1995 – 2009 were included (Table 4). 
These studies, mainly of MMR examined: 
▪ The affect of adverse publicity on MMR uptake, 
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▪ Susceptibility to MMR in Ireland, 
▪ Progress of a ‘catch-up’ programme in Wales, 
▪ General practice factors associated with MMR coverage, 
▪ Uptake of combined MMR and single antigen vaccines, 
▪ Primary immunisation status and MMR uptake, 
▪ Factors associated with partial immunisation, 
▪ Continuity of care and MMR, 
▪ Uptake of pre-school booster, 
▪ MMR and older siblings, 
▪ MMR uptake by ethnic group, 
▪ MMR uptake and social deprivation, 
▪ Call or recall systems, 
▪ Neighbourhood uptake of MMR in Canada, 
▪ Under-reporting of MMR in Sydney, Australia, 
▪ MMR uptake among 10-11 year olds and HepB uptake among 13-14 year olds in 
Australia. 
 
The conclusions from these studies were that: 
▪ Having a strategic approach and easy access is important for general practices 
(Lamden & Gemmill, 2008). Immunisation records need to be up-to-date (Hawker 
et al, 2007). Strategies are needed to improve accurate reporting of coverage 
(Lawrence et al, 2003). Reminders of immunisation appointments and more 
accessible opportunities might be successful (Pearce et al, 2008). Practical 
suggestions include: Improving access to clinics, reducing inconveniences, home 
immunisation, flexible clinic times, flexible locations (Reading et al, 2004). In 
Seattle, USA, greater continuity of care is associated with MMR uptake (Christakis 
et al, 2000). 
 
▪ MMR uptake varies between ethnic groups, with the lowest uptake in Black 
Caribbean children and the highest in Asian children, so ethnic data should be 
uniformly collected (Hawker et al, 2007). The greater the deprivation, the greater 
the tendency for late vaccination, especially in the most deprived category 
(Friederichs et al, 2006). The lowest rates of MMR coverage remain in urban 
areas, particularly inner cities, which also tend to show high levels of deprivation 
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(Wright et al, 2005). Social differentials in uptake could be used to inform targeted 
interventions to promote uptake (Pearce et al, 2008). Effective targeting of 
children living in deprived electoral wards could improve pre-school booster 
uptake (Evans & Thomas, 1998). Public health resources should continue to 
target inner city areas (Wright et al, 2005). 
 
▪ Lone parenthood was identified as an important independent risk factor in London 
for non-completion of immunisation at 12 months, whilst unemployment may 
facilitate uptake as the parent does not have to take time off work to attend the 
clinic (Sharland et al, 1997). In Canada, there are significant inequalities in uptake 
which may be due to access to health centres, lack of a car or lack of support for 
single mothers (Avis et al, 2007). Practical help with child care may help (Reading 
et al, 2004). Targeting families for a domiciliary immunisation service may improve 
coverage (Sharland et al, 1997). 
 
▪ Children who remain unimmunised with primary vaccines are also more likely not 
to receive MMR (Pearce et al, 2009). Infants with older siblings are less likely to 
be immunised on time (Reading et al, 2004). 
 
▪ Children remain susceptible to infection because of parents’ decision not to 
immunise (Pearce et al, 2008). Mothers of unimmunised infants differ in age and 
education from those of partially immunised infants (Samad et al, 2006a). 
Strategies are needed to address parental knowledge about the MMR (Lawrence 
et al, 2003). Ready access to evidence-based information about MMR is needed, 
tailored to particular concerns and beliefs of different groups (Pearce et al, 2008). 
Tailored information or improved access may help (Pearce et al, 2009). Practical 
suggestions include addressing concerns in immunisation advice in an unbiased 
and reasoned way (Reading et al, 2004). Different approaches are needed for 
different mothers (Samad et al, 2006a). Public health resources should focus on 
the concerns of the better educated about vaccine safety (Wright et al, 2005). 
 
▪ The ‘catch-up’ programme may not have reached all the children in Wales in 1998 
who most needed to be immunised (Thomas et al, 1998). 
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▪ Relatively little was known about the adolescent immunisation MMR and hepatitis 
B target population in Australia (Skinner et al, 1998). Further consideration was 
needed about the delivery in schools, clinics or by GPs (Skinner et al, 1998). 
 
▪ A primary school top-up programme appeared to be necessary in Dublin in 1995 
(Johnson et al, 1995). In Australia, school entry requirements appeared to be a 
primary driver for the 2nd MMR (Lawrence et al, 2003). 
 
5. Evidence summary from studies of health care professionals 
Data from four studies reporting from 2001 – 2008 focussed on assessing healthcare 
professionals’ views in relation to immunisation uptake were included (Table 5). An 
overview of the concepts explored in these studies is presented below: 
▪ Knowledge, attitudes and practices, particularly related to the 2nd MMR dose, 
▪ Confidence in the vaccine following media coverage, 
▪ Concerns about vaccine safety, 
▪ Benefits of vaccination, 
▪ Confidence in discussing issues with parents, 
▪ Further training in vaccination issues. 
 
Knowledge about vaccine 
There appears to have been a significant fall in confidence about the MMR vaccine, 
in relation to safety and adverse side-effects, amongst healthcare professionals. Two 
studies that explored knowledge and attitudes towards the 2nd dose of MMR in 
particular found that a large number of healthcare professionals were unsure of the 
need for a 2nd dose, and that more research was warranted (Smith et al, 2001; 
Petrovic et al, 2001). A large proportion of practice nurses thought there was a link 
between MMR and Crohn’s disease or autism, and one fifth of GPs reported that they 
had not read the relevant guidance on MMR (Petrovic et al, 2001). 
 
Confidence with parents 
The GP’s role in education would appear to be central but many are afraid that 
broaching the subject with parents would put them off vaccination altogether (Pareek 
& Pattison, 2000). Health visitors and practice nurses were most often nominated as 
the best source of immunisation advice, with more health visitors reporting feeling 
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confident about discussing the vaccine with parents, compared to GPs (Petrovic et 
al, 2001). However in one study, practice nurses and health visitors reported less 
confidence than GPs (Smith et al, 2001). In all the studies, it was cited that ‘further 
training on immunisation issues’ was required. 
 
Summary of recommendations from health care professionals’ questionnaires 
Further education initiatives should include all healthcare professionals involved in 
immunisation. Educational sessions may be combined with other measures shown to 
be effective, including reminders to doctors about children requiring vaccination, and 
assessment and feedback to practices on the vaccination coverage of children 
registered with them; 
 
6. Evidence summary from surveys or questionnaires of parental views 
Data from fifteen studies found to be relevant exploring parental views on 
immunisation, both from those groups who had and had not had their children 
immunised, were extracted (Table 6).  
 
The parental studies explored the following concepts: 
▪ Knowledge, attitudes and concerns of parents who had not completed 
immunisation, 
▪ Comparing views of triple versus single vaccines, 
▪ Reasons why parents choose not to vaccinate, 
▪ Parental beliefs about MMR, 
▪ Social and cultural influences, and health beliefs associated with low uptake, 
▪ Intentions to vaccinate, 
▪ Factors associated with non-uptake of the 2nd dose of MMR, 
▪ Factors relevant to immunising and non-immunising parents and the extent to 
which these factors predicted decisions, 
▪ Understanding of vaccine-preventable diseases, immunisation policies and 
practices, 
▪ Concerns about vaccine safety. 
 
Findings from the parental studies can be summarised into the following categories: 
 
 22 
Information 
A common finding was that parents lacked confidence in sources of information 
regarding the MMR vaccine. There appears to be an element of mistrust of the 
advice given by healthcare professionals, the government and through the media. 
Children’s healthcare providers or GPs were often cited as the most important & 
trusted source of information about MMR (Pareek & Pattison, 2000; Gellin et al, 
2000), but in one study, the most common source of information on side-effects of 
the vaccine was found to be the television (Pareek & Pattison, 2000). Another study 
found that ‘non-acceptors’ of the 2nd MMR dose were more likely to report having 
received information from newspapers or TV, and more likely to report having a lot or 
some influence from these media (Petrovic et al, 2003). One study reported that the 
influence of current research and the helpfulness of information packs significantly 
predicted vaccination status (Gellatly et al, 2005). 
 
Vaccine safety 
The majority of parents have concerns regarding the safety of the MMR vaccine 
(whether they choose to have their children immunised or not), but those parents 
who decline the vaccination tend to have stronger views on the overall practice of 
immunisation, with some perceiving it as an ‘overload’ for their child’s immune 
system (Gellin et al, 2000). One study found that fewer mothers intended to take their 
children for the 2nd MMR vaccination compared with the 1st dose, expressing more 
negative beliefs about the vaccine outcome, safety and efficacy (Pareek & Pattison, 
2000). The most common reason cited for not accepting the 2nd dose in another 
study, was that ‘the child had had one dose already and that this was deemed 
enough’ (Petrovic et al, 2003). 
 
Risk 
Perception of risk was often explored in these studies, and those parents who 
choose not to vaccinate their children with MMR often cited that they thought the 
vaccine was more risky than any of the illnesses that can occur. The importance of 
eradication of rubella was found to significantly predict vaccine uptake in one study 
(Gellatly et al, 2005). Another study reported that parental decisions were explained 
by emotion-related variables, specifically ‘anticipated responsibility and regret’, and 
that decisions are strongly influenced by the idea ‘that harm that occurs as a result of 
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deciding to immunise is less acceptable than harm that occurs as a result of deciding 
not to immunise’ (Wroe et al, 2005). 
 
Perceived knowledge 
A greater proportion of parents with unvaccinated children reported they had some 
‘knowledge’ of MMR, but in fact they had less accurate information about the vaccine 
(Alfredsson et al, 2004). One study reported that ‘non-compliers’ were significantly 
more likely to have attended public meetings on immunisation, had read books on 
MMR and seen documentaries. Significantly more of these parents had also 
consulted a homeopath. Rejection of the vitamin K injection routinely offered at birth, 
was also strongly associated with non-uptake (Cassell et al, 2006). 
 
Summary of recommendations from surveys or questionnaires of parental views 
▪ Parents require information that is up-to-date, tailored to their individual needs 
and provided by healthcare professionals who are well informed; 
▪ Communication efforts should focus on clarifying and reaffirming parents’ 
correct beliefs about immunisation and on modifying misconceptions; 
▪ School entry and at times when other vaccinations are given would be a good 
opportunity for catch-up; 
▪ Educational campaigns need to emphasise the safety of MMR and the danger 
of vaccine-preventable diseases, but which also emphasise the efficacy of the 
vaccine and delineate the rationale behind the two-dose schedule; 
▪ Science stories could be turned into ‘narratives’ that are interesting, accessible 
and informative; 
▪ Healthcare professionals have to take time to listen to and discuss parental 
concerns, and it needs to be taken into account that parental knowledge or 
views may not be based on scientific data. 
▪ A ‘diagnostic analysis’ should be undertaken to identify obstacles to change, 
and that any intervention planned should be targeted at overcoming them. 
 
Whilst the above findings are helpful, it is important to acknowledge that 
questionnaires and surveys have methodological limitations and care should be 
taken when interpreting results. Limitations found in the studies reported here were: 
▪ Low response rates, 
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▪ Non-response bias (i.e. survey not representative), 
▪ Questionnaires not validated or piloted, 
▪ Recall bias, 
▪ Instruments not culturally appropriate, 
▪ Lack of robust statistical analysis. 
 
7. Evidence summary from qualitative studies 
Fourteen papers relating to nine qualitative studies were identified that were relevant 
to the aims of the review were included (Table 7). The majority examined parents’ 
decision making associated with first dose of MMR (MMR1) vaccination and the 
concerns and issues that influenced the decision-making process. One paper 
(Morgan et al, 2003) focussed specifically on parents of children exposed during a 
measles outbreak in a nursery school and their responses to offers of MMR 
vaccination. The studies identified cover Scotland and England but no qualitative 
papers were identified from Wales or Northern Ireland. Two papers (Morgan et al, 
2003; Petts & Niemeyer, 2004) used mixed methods but only the qualitative data is 
reported in this summary. Four papers (McMurray et al, 2004; Brownlie & Howson, 
2005a; Brownlie & Howson, 2006; Poltarak et al, 2005), analysed the views of health 
care professionals (HCPs) involved in immunisation specifically health visitors (HVs) 
and general practitioners (GPs) in addition to parents. Three papers specifically 
targeted recruitment of Asian (Petts & Niemeyer, 2004; Mixer et al, 2007), Afro-
Caribbean (Mixer et al, 2007) and Orthodox Jewish parents (Henderson et al, 2008). 
 
A striking feature of all the papers was that few, if any, parent approached the subject 
of immunisation and particularly MMR without some degree of fear which reflects the 
enormous public health challenge this presents. 
 
The key narratives that emerged from the studies were: 
▪ Lay understandings of immunity, 
▪ Mumps, measles and rubella memory, 
▪ Parental choice versus responsibility to others, 
▪ Good and bad parents, 
▪ Interpreting information to assess risk, probabilities and judging truthfulness, 
▪ Role of Social networks in MMR talk and decision making , 
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▪ Distrust of health care professionals, 
▪ Distrust of government and public health , 
▪ Impact of the media in constructing distrust. 
 
Lay understandings of immunity 
A number of narratives emerged that diverge from the professional message of 
increased protection offered by immunisation. A child’s immune system was 
considered in most parental accounts as essential to overall health, but inherently 
fragile, susceptible to stress (Evans et al, 2001) and vulnerable to threats (Poltarak et 
al, 2005). Hence children in general, and some children specifically, need protection, 
e.g. those with premature births, those with allergies, asthma and, or eczema, 
(Poltarak et al, 2005; Casiday, 2007). Protecting a child from immunological threat is 
a parental responsibility and any decision to vaccinate involves weighing up the 
individual child’s ability to cope with the assault. Parents as the expert of their child 
are the only ones able to judge that ability to cope, the child’s ‘particularity’ (Poltarak 
et al, 2005). Parents recognised that some children were healthy and some 
vulnerable (Raithada 2003; Poltarak et al, 2005; Casiday, 2007; Skea et al, 2008), 
this dichotomy was significant in terms of hardiness to cope with the effects of 
vaccination and/or building greater resistance through exposure to infectious 
diseases. Healthy children, not all children, were identified by some as the ones that 
should contribute to public health of others through immunisation (Skea et al, 2008). 
 
The routinisation of childhood immunisation had traditionally created a confidence 
based on its ordinariness; this trust had been broken in the UK by the Wakefield 
controversy (Brownlie & Howson, 2005). This loss of trust in immunisation is not 
unique to the UK. For example vaccine controversies exist in the US linked to oral 
polio vaccine and preservatives used in the Hepatitis B vaccine (Daniels, 2002). 
Combined vaccines were perceived as presenting greater threat due to the 
magnitude of the immunological burden (Casiday 2007), thus overloading immature 
immune systems, particularly the vulnerable. There was much confusion across the 
studies surrounding the single versus combined vaccines. Injection of foreign 
‘disease’ based substances for some parents was symbolically a powerful negative 
image (Henderson et al, 2008). However these arguments were far from consistent 
as many parents had accepted DPT at an earlier point. The threat posed by the MMR 
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vaccine was perceived as greater (Hilton et al, 2006b) than DPT. One explanation 
offered was that parents are more vaccine naïve when DPT is offered and therefore 
more likely to be vaccine compliant; whereas later after they have been exposed to 
‘MMR talk’ (Poltarak et al, 2005; Brownlie & Howson, 2005; Henderson et al, 2008) 
they more likely to adopt the position that MMR immunisation posed a threat to their 
child. 
 
Mumps, measles and rubella memory 
The perception of threat from vaccine–preventable infections could be considered a 
successful outcome of public immunisation programmes (Raithada et al, 2003; Hilton 
et al, 2006a). In a number of the studies parents had reported contracting one or 
more of the conditions in childhood and most saw them as minor illnesses (Evans et 
al, 2001; Morgan et al, 2003; Hilton et al, 2006a). Acquiring minor illnesses was seen 
by some as contributing to building natural immunity (Evans et al, 2001; McMurray et 
al, 2004) and acquiring measles meant (erroneously) that MMR immunisation was 
unnecessary (Morgan et al, 2003). Experience of (McMurray et al, 2004), or 
knowledge of the serious side effects of measles (Petts & Niemeyer, 2005; Skea et 
al, 2008) such as deafness positively influenced uptake of MMR1 for some, and was 
particularly important in informing decisions to immunise among Asian parents (Mixer 
et al, 2007). Experience of measles, including outbreaks, failed to alter resistance to 
MMR immunisation for some (Evans et al, 2001; Morgan et al, 2003). 
 
Some confusion appeared to exist about what exactly German measles was. Some 
parents were unclear if it was the same disease as rubella whereas others the 
preface ‘German’ was a slang term for measles (Hilton et al, 2006a). Some parents 
felt they were deceived into agreeing to immunise their sons against rubella as they 
would not get pregnant in later life and therefore it did not pose a health risk (Hilton et 
al, 2006). Mumps was not seen as a serious disease (McMurray et al, 2004), indeed 
more a childhood rite of passage and somewhat comical. It was linked by some 
parents with male infertility (Evans et al, 2001; Hilton et al, 2006a) and therefore seen 
as more significant for boys to receive protection than girls. All these arguments were 
more likely to be offered by parents in favour of single vaccine immunisation 
programmes (Brownlie & Howson, 2005). Learning about mumps, measles and 
rubella ‘sold’ MMR immunisation to parents (Petts and Niemeyer, 2004). 
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Parental Choice and responsibility to others 
A parent’s own child’s health took priority over any responsibility to others (Casiday, 
2007). Some factors such as informed rejection of Vitamin K at birth may be a 
predictor of MMR1 rejection (Poltarak et al, 2005); as might exposure to autism and, 
or MMR diseases might influence MMR1 acceptability (McMurray et al, 2005). 
 
Making an assessment of whether their child was healthy rather than vulnerable 
contributed to a parent acting for the greater good by accepting their responsibilities 
to public health and herd immunity (Skea et al, 2008). Information plus an opportunity 
to quiz experts appeared to increase understanding of the benefits of mass 
vaccination for population protection (Petts & Niemeyer, 2004). 
 
Good and bad parents 
A good parent (to parents) was one that made the right immunisation decision for 
their child (Casiday, 2007). An aspect of making the right decision, and therefore 
being a good parent, was weighing up the probability of their child being vulnerable to 
any adverse outcomes of immunisation (Casiday, 2007). That said, some immunisers 
judged those parents who chose not to immunise ‘healthy’ children as bad parents 
(Skea et al, 2008) as they had greater responsibility to others. 
 
Very few parents reached a decision about MMR vaccination on moral, religious or 
ideological grounds (Brownlie & Howson, 2005). Religious beliefs predicated on 
notions of no personal control over events did not protect parents from worrying 
about making the right decision (Petts & Niemeyer, 2004). 
 
Some parents felt they were judged, by GPs and social services as good or bad by 
their willingness to comply with MMR immunisation invitations, (Poltarak et al, 2005). 
Indeed GPs perceived non-compliance or chronic immunisation default was greater 
among the poor whereas evidence suggests that MMR uptake decline was greater in 
affluent areas (Brownlie & Howson, 2006). Parents felt that if they asked questions 
they would be seen as being a nuisance by HCPs. Indeed one informant whose child 
was immunised reported "I'm sure they've got it on my file, "neurotic mother"." (Evans 
et al, 2001). Parents who participated in social network with other parents, such as 
Toddler Groups, were more likely to be perceived positively by others if they at least 
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discussed the risks, engaged in MMR talk, from immunisation. Parents who chose 
not immunise and their child subsequently developed an infectious disease felt 
exposed to criticism from others (Raithatha et al, 2003). 
 
Interpreting information to assess risk, probabilities and judging truthfulness 
Decision-making around immunisation does not appear to be fixed; rather parents 
change their position over time, respond differently to some vaccines and make 
separate decisions for each child (Evans et al, 2001; McMurray et al, 2004; 
Henderson et al, 2008). No position was perceived as risk free, or safe, and decision-
making involved navigating the territory of risk (Petts & Niemeyer, 2004; Casiday, 
2007). Balancing the relative probabilities of autism versus measles were factors, but 
other risks such as social concerns (being perceived as a bad parent), or other health 
issues such as allergies were factors. 
 
Information to assist decision making was insufficient, unreliable and health 
professionals, particularly GPs, unavailable to discuss concerns (Evans et al, 2001; 
Nagaraj, 2006). Information generally did not meet needs as truthfulness was judged 
on credentials (source), messenger, ease in which information could be incorporated 
into existing understandings and then applied to the discrete decision (McMurray et 
al, 2004). 
 
Role of social networks in MMR talk and decision making 
Autonomy and personal choice are significant issues surrounding pregnancy and for 
many it is the first significant engagement with balancing risk and choice in the 
context of personal health care. Once parents’ birth experiences and managing 
ongoing choice are intertwined as is the experience of being with other parents 
(Poltarak et al, 2005). Other parents were seen as impartial sources of evidence, 
having no hidden agendas and their accounts were accessible and believable (Hilton 
et al, 2007). Paradoxically in another study they were perceived as poor sources of 
trustworthy information but important sources (Petts & Niemeyer, 2004). 
Nevertheless parenthood is a time when parents, most frequently mothers, engage in 
talk with others similarly placed. The relationship between talking about MMR and 
building relations with other mothers resulted in a failure to challenge concerns 
voiced by others about MMR safety. To not show concern about vaccine safety was 
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to be different (Poltarak et al, 2005) particularly when to bracket out uncertainties 
requires adopting a position of faith. 
 
Mothers and parents are subject to MMR babble through which they navigate. This 
talk comes from multiples sources and is often conflicting and confusing. In MMR 
decision-making they have to make a ‘leap of faith’ and suspend belief in a particular 
position; suspension occurs within relationships and networks (McMurray et al, 2004; 
Petts and Niemeyer, 2004; Brownlie & Howson, 2005; Poltarak et al, 2005; 
Henderson et al, 2008; Skea et al, 2008). 
 
Distrust of health care professionals 
Impartiality of health care professionals was questioned (Hilton et al, 2007). Financial 
incentives received by GPs to promote MMR uptake created feelings of distrust 
(Evans et al, 2001; Petts & Niemeyer, 2004; Hilton et al, 2007), as was health care 
professionals willingness to follow the official line (McMurray et al, 2004). GPs’ 
unwillingness to openly discuss, appeared dismissive or coercive and compounded 
parental distrust (Evans et al, 2001; McMurray et al, 2004). Efforts made by GPs to 
focus on the ‘particularity’ of the child and show concern were viewed positively 
(Casiday, 2007), as were personal relationships with health providers (Casiday, 
2007; Skea et al, 2008). Motivations of HVs whose tone was overly resolute, or in 
contrast vague, were equally questioned (Hilton et al, 2007). Interestingly HVs 
reported that immunisation targets worked counter to their role as parent advocate 
and official information was insufficient to support informed choice (Brownlie & 
Howson, 2006). Further the levels on information accessed by parents made it 
difficult for HVs to treat parents other than homogenously, compete with volume of 
research, or keep up to date (Brownlie & Howson, 2006). 
 
Embedded culture of trust in health care professionals linked to an almost reverence 
of medical expertise was highlighted as a factor in Asian parent decision-making 
(Petts & Niemeyer, 2004). Less awareness of single vaccines as an alternative to 
MMR was evident in the accounts from Asian parents (Mixer et al, 2007). Overall 
greater receptiveness and higher MMR uptake in Asian and Turkish communities 
were identified (Mixer et al, 2007; Anderson et al, 2008). 
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Opportunistic immunisation opportunities presented by visits to Out Patient 
Departments (OPDs) or Accident & Emergency (A&E) were perceived placing as 
undue pressure on parents to comply (Evans et al, 2001). 
 
Distrust of government and public health 
Government and particularly politicians were not seen as trustworthy in matters of 
health (Hilton et al, 2007). The recent origins of this distrust in government was their 
management of BSE in the early 1990s (Evans et al, 2001; Raithatha et al, 2003; 
Casiday, 2007), but compounded by Tony Blair’s failure to confirm whether his son 
was immunised. This raised serious doubts about the safety of MMR vaccine among 
parents (Petts & Niemeyer, 2004). Government attempts to reassure following the 
sensationalised accounts of the autism-MMR link were treated with scepticism 
(Evans et al, 2001) yet parents needed to evaluate evidence for themselves 
(Casiday, 2007). Andrew Wakefield was not universally discounted, or recognised as 
discredited by parents and some saw him as a whistleblower (Hilton et al, 2007). 
 
HVs delivering targets for GPs who themselves are working to deliver the 
governments agenda undermines professional judgement and undermines 
professional self regulation (Brownlie & Howson, 2006). 
 
Impact of the media in constructing distrust 
Two media representations of MMR have been sustained. One, the risk of autism 
from the triple MMR vaccine and, two, low uptake of MMR being represented as a 
‘social problem’ (Brownlie & Howson, 2006). Although many parents recognised the 
scaremongering aspects of the media, and spoke negatively about the reporting of 
the Wakefield controversy, nevertheless found accounts relating to MMR and autism 
and bowel conditions compelling, and doubt-raising (Hilton et al, 2007). Even in 
parents who previously had not questioned the safety of immunisation (Evans et al, 
2001). Health professionals perceived the media representations as undermining 
(Brownlie & Howson, 2006). 
 
Level of integration, language and low level reporting of the link to autism in the 
Indian press was suggested as an effective barrier for minimising the effect of the 
media on MMR uptake among Asian parents (Mixer et al, 2007), This was not 
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mirrored in the Orthodox Jewish community where media seepage irrespective of 
level of community integration was thought to be influential (Henderson et al, 2008). 
 
The use of real life stories to communicate information was seen as a particularly 
persuasive device (Petts & Niemeyer, 2004; Hilton et al, 2007; Casiday, 2007) by 
parents. 
 
Uptake of second dose of MMR  
Petts & Neimeyer (2004) who did a study of two focus groups with a health promotion 
intervention and found 15 of 64 (23%) participants did not know a booster was 
required at 5 years, including parents who had already had the first MMR. McMurray 
et al (2004) differentiated between a group of parents who had declined the second 
MMR but who had their child immunised with the first MMR, and another group who 
not yet had their child immunised with the second MMR but had immunised with the 
first MMR. "Reluctant vaccinators" agreed to having the MMR2 despite doubts, based 
on their assessment of a likely outcome of autism rather than the effect. Two factors 
influenced pro-second MMR uptake assessments in reluctant parents, and these 
were firstly, no detected problems with the first MMR and secondly, no evidence of 
autism in "their immediate social sphere" (McMurray et al, 2004).  
 
Summary of recommendations 
Health care professionals need to recognise the complexity of MMR decision-making 
for parents. The decision to immunise involves parents in a process of balancing 
risks and probabilities and a ‘leap of faith’ (Brownlie & Howson, 2005a). Health care 
professionals need to engage in trust building if they are to (re)gain the confidence of 
parents. This requires HCPs to allocate time and provide space for parents to 
discuss fears without engendering feelings that they must comply, or that their 
opinions are without credibility. This may be particularly important when increasingly 
the public have less confidence in expert knowledge, and the honesty of those in 
positions of power, and turn to alternative sources. 
 
Information giving needs to be responsive and personalised, and personal 
disclosures by health care professionals may be valued in the context of 
immunisation. Information needs to appear balanced, should recognise the 
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controversy created by Wakefield, and acknowledge vaccination is not without risk. 
Informal opportunities and forums (such as Toddler Groups) might afford spaces 
where parents can discuss concerns with HCPs, or other ‘champions’, in an open 
and non threatening way. Direct attacks on Wakefield and his alternative views may 
be counterproductive and merely serve to increase his status, albeit discredited, as a 
defender of the concerns of ordinary parents. HVs and GPs may need to distance 
themselves from financially incentivised targets and act with professional autonomy 
with parents to support them through decision-making. 
 
Measles, mumps and rubella are poorly understood as diseases, and as public 
health threats. The potential dire consequences of measles was not necessarily seen 
as a health problem for children in an affluent country like the UK, indeed there was 
considerable weight behind the misplaced view that exposure might bring health 
benefits such as enhanced resistance to other infectious diseases thus making the 
child stronger. The different sequelae of rubella and mumps exposure for girls, and 
boys, appeared poorly understood, this may contribute to increased requests for 
single vaccines or non-compliance. Information should communicate the immediate 
risks that can occur as a consequence of contracting the diseases, and potential 
impact on those who may be put at risk through inadvertent exposure. This may be 
best achieved through use of personal accounts and stories. 
 
Social networks appear to be particularly significant in influencing the decision to 
immunise against MMR. Other mothers (friendship networks) and elders (e.g. 
grandparents) and relatives (kinship networks) appear to be particularly significant. 
Strategies that identify role models and champions for MMR immunisation that could 
then influence MMR uptake may bring sizeable benefits. 
 
Limitations of the studies 
There was a tendency to recruit parent populations from toddler groups and, or GP 
practices this may have inadvertently excluded some parents such as those in full 
time employment. In keeping with qualitative tradition, sampling was largely 
purposive, or convenience. Some attempts were made to achieve greater 
representation across social classes, in some cases ethnicity and include fathers. 
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The majority of the reports were dependent on data collected in the aftermath or the 
following five years since the original Wakefield controversy hit in 1998. The regular 
reporting of outbreaks of measles may begin to change opinion and this would be 
useful to capture. 
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SUMMARY AND CONCLUSIONS 
Summary of evidence of groups where uptake is lower 
This review has identified, mainly from the examination of existing datasets, a 
number of groups where coverage for MMR is likely to be lower. These are children: 
▪ Living in deprived electoral, urban areas, particularly inner cities, (Pearce et al, 
2008; Friederichs et al, 2006; Samad et al, 2006a; Wright et al, 2005; Evans & 
Thomas, 1998), larger family size, 
▪ With a lone parents (Pearce et al, 2008; Sharland et al, 1997; Avis et al, 2007), 
▪ Who are Black Caribbean in Birmingham (Hawker et al, 2007), 
▪ In a family where there is no car (Avis et al, 2007), 
▪ Who have older siblings (Pearce et al, 2008; Reading et al, 2004), 
▪ Who remain unimmunised with primary vaccines (Pearce et al, 2009), 
▪ With a mother aged under 20 (Pearce et al, 2008), 
▪ With a mother aged over 34 when they were born, (Pearce et al, 2008), 
▪ With a mother who was more highly educated (Pearce et al, 2008; Wright et al, 
2005), 
▪ With a mother who was not employed (Pearce et al, 2008), 
▪ With a mother who was self-employed (Pearce et al, 2008). 
 
The review has also identified that children who are more likely to be partially 
immunised are those: 
▪ Resident in wards with disadvantage (Samad et al, 2006a), 
▪ In ethnic wards (Samad et al, 2006a), 
▪ In a larger family (Samad et al, 2006a), 
▪ With a lone parent (Samad et al, 2006a), 
▪ With a teenage parent (Samad et al, 2006a), 
▪ Whose mother smoked in pregnancy (Samad et al, 2006a), 
▪ Who were admitted to hospital by 9 months (Samad et al, 2006a). 
 
The review has also identified that children more likely to have a delay in pertussis 
immunisation are those: 
▪ With more older siblings (Reading et al, 2004), 
▪ Without housing tenure (Reading et al, 2004), and 
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▪ According to the mother’s social class when the child was an infant (Reading et al, 
2004). 
 
The children who are more likely to receive a single vaccine are those whose 
mothers are older, better educated and where there is a higher household income 
(Pearce et al, 2008). 1.9% of mothers of unimmunised infants were educated to 
degree level or above and 3.1% were aged 40 or more (Samad et al, 2006a). 
 
Pre-school booster coverage was more likely to be lower among children living in 
urban areas and in more deprived electoral wards (Evans & Thomas, 1998). 
 
Summary of reasons for incomplete immunisation 
The review has identified that the reasons most commonly reported by parents for 
incomplete vaccination are: 
▪ Lack of knowledge about the age the second dose was due (29%) (Lawrence et 
al, 2003) 
▪ Medical reason of contra-indications to MMR vaccination (15%-18%) (Pearce et 
al, 2008; Lawrence et al, 2003), 
▪ A practical reason (6%) (Pearce et al, 2008), 
▪ Forgetting the MMR was due (16%) (Lawrence et al, 2003), 
▪ Disagreement or concern (14%), most commonly because of the perception that 
the risks outweighed the benefits (Lawrence et al, 2003). 
 
Many partially immunised children have only minor conditions, such as upper 
respiratory tract infections which might warrant deferral rather than contra-indicate 
future immunisation (Samad, 2006b). Following up these parents would help ensure 
the course of immunisation was complete. 
 
The review has identified that some of the reasons why parents choose not to 
vaccinate are that: 
▪ Parents lack confidence or trust in sources of information regarding the MMR 
vaccine, 
▪ Parents have concerns regarding the safety of the MMR vaccine, 
▪ Parents think the vaccines are harmful and more risky than any of the illnesses, 
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▪ Parents think that the diseases are harmless or even beneficial, 
▪ For a child who had had one dose already that this is deemed enough, 
▪ Acquiring minor illnesses is seen as contributing to building natural immunity and 
acquiring measles meant that MMR immunisation was unnecessary, 
▪ Not enough time was allocated for questions and discussions. 
 
Summary of issues relating to health care professionals 
The review has identified that since 1998 there has been: 
▪ A significant fall in confidence among health care professionals about the safety 
and adverse side-effects of MMR, 
▪ A large number of healthcare professionals were unsure of the need for a 2nd 
dose, 
▪ Practice nurses and health visitors reported less confidence than GPs, 
▪ Further training on immunisation issues was required. 
 
Summary of evidence of effectiveness of structural interventions 
The review has identified that there is evidence of the effective of the following in 
improving the uptake of immunisation: 
1. Having a strategic approach, 
2. The use of computers in primary care, 
3. Audit and feedback to practices, 
4. Patient reminder and recall systems, especially a postal reminder, followed by a 
telephone call, 
5. Education for health care professionals. 
 
In addition, the review has identified some practical difficulties for which there is 
currently no evidence of effectiveness. For example, practices need to be more 
flexible in providing easy access for some parents, as illustrated in the quotation 
below, (Samad et al, 2006b). 
 
“ . . . transport problems due to having two small children . . . and the 
surgery is quite far away and they only do the surgery on Wednesday 
and I can’t get from the nursery to the surgery easily.” 
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Parents requirements prior to immunisation 
The review has identified, from parent questionnaires and from the qualitative data, a 
series of issues from parents’ perspective. Childhood immunisation is more of a 
process than an isolated action and the decision to vaccinate may be influenced by 
factors other than risk (Hobson-West, 2003).  
 
Whilst we did not find evidence of the effectiveness of the following issues, we 
highlight here possible methods that have been recommended to address parents’ 
concerns about immunisation.  
 
It is recommended that primary care strategies are needed to help parents make an 
informed choice about vaccination for their infant. Parents need access to trusted 
support and information which: 
▪ Is provided by a trusted healthcare professional who is well informed, takes time 
to listen to and discuss parental concerns, 
▪ Helps parents to understand that measles, mumps and rubella are seen as public 
health threats, 
▪ Treats every immunisation as different and special for those parents who wish to 
discuss before deciding,  
▪ Provides ready access to reliable evidence-based information about MMR, 
▪ Provides information about the danger of vaccine-preventable diseases, 
▪ Addresses parental knowledge about the safety and adverse side-effects of MMR, 
▪ Addresses any misconceptions about contra-indications, 
▪ Is tailored information to particular concerns and beliefs of different groups, 
▪ Is easily incorporated into existing understandings, 
▪ Address concerns in immunisation advice in an unbiased and reasoned way, 
▪ Offers different approaches for different mothers, 
▪ Uses ‘narratives’ or real life stories that are interesting, accessible and 
informative, 
▪ Explains specifically the different sequelae of rubella and mumps exposure for 
girls, and boys, 
▪ Takes into account that parental knowledge or views may not be based on 
scientific data. 
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Immunisation in non primary care contexts 
Although the focus of this review has been on identifying interventions to maximise 
the uptake of primary infant immunisation and MMR, there are particular groups of 
children and parents with particular needs in relation to immunisation. Where 
possible, primary health care practitioners should seek opportunities to collaborate 
with secondary care services, such as A&E and paediatric wards, education and 
social care, to develop, implement and evaluate innovative cost-effective 
interventions, to maximise the uptake of childhood immunisation among the whole 
community.  
 
Hospitals 
In a study in England and one in America, children who were hospital in-patients 
(Conway et al, 1999) or who attended and Accident and Emergency context 
(Schenker et al, 1995) were identified as eligible for vaccination for a missed or late 
immunisation. The proportions children who were eligible and who were vaccinated 
were 15% and 25% in the English and American studies respectively (Conway et al, 
1999; Schenker et al, 1995) indicating that hospital attendance provides opportunities 
for catch up and routine immunisation. 
 
Schools 
School-based programmes are intrinsically more successful at maximising uptake of 
vaccination because they have a ‘captive audience’ (Skinner at al, 1998). Within 
school immunisation programmes, the issue of absenteeism has to be addressed 
(Skinner at al, 1998). ‘Mop-up’ vaccination days have been advocated as a method 
of maximising uptake, requiring the full child outcomes-operation of schools, parents 
and health services. 
 
A school immunisation programme could be effective, if it incorporates the successful 
elements from an Irish study (Joyce-Cooney et al, 2003). The elements were a 
dedicated team, the active follow-up of all defaulters, a comprehensive database 
made available to schools; availability of telephone numbers, a dedicated telephone 
line, and avoidance of deferral for minor illness. 
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In some countries, vaccination is required either before nursery or school. Each 
Australian state and territory has legislation that requires evidence of a child’s 
vaccination history when they start school (Lawrence et al, 2003) and parents appear 
to know more about the school entry requirements than the Australia Standard 
Vaccination Schedule (Lawrence et al, 2003). In the UK the DH and the British 
Medical Association do not consider compulsory vaccination as an option (POST, 
2004). 
 
Universities 
One study explored factors influencing MMR decisions following mumps outbreak on 
a university campus in Kent (Hamilton-West, 2006). Students and staff were advised 
to attend for immunisation but only a third of the sample chose to have the 
immunisation. Students were unlikely to have an injection when the perceived risks of 
immunising were equivalent to the perceived risks of not immunising (Hamilton-West, 
2006). 
 
Children looked after by the local authority 
A study of 593 children looked after by a single health authority found that the 
children received poor health supervision and that the children aged 2-5 years were 
significantly less likely to be immunised against diphtheria, tetanus, pertussis, polio, 
Hib and MMR compared with the whole of the county population of 2-5 year olds 
(Payne & Butler, 1998), further contributing to disadvantage among these children. 
Missing records contributed to the problem. The authors suggested that a person 
should be nominated with protected time to take responsibility for monitoring and 
improving the health of this population of looked after children (Payne & Butler, 
1998). 
 
Young, single mothers 
Among lone parent families there are single, separated, divorced and widowed 
mothers. They may experience difficulties with arranging time off work, low income, 
dependence on public transport, temporary housing, or poor motivation to immunise 
(Sharland et a, 1997). 
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Targeting lone parents (Sharland et al, 1997) or parents of infants with older siblings 
(Reading et al, 2004) for a domiciliary immunisation service may improve coverage 
by overcoming some of the practical barriers for parents to increase the chance that 
the infant will to be immunised on time. 
 
In two studies, one of 290 poor, black mothers living in an Eastern US city (Hardy & 
Street, 1989) and another of 262 mothers living in a deprived area in Dublin (Johnson 
et al, 1993), support was offered in the form of ten to twelve home visits from 
experienced, specially trained, mothers, who had lived in the community previously. 
The intervention provided education and encouraged the mothers to keep 
appointments at well-baby clinics. A third study of a service for 243 black, unmarried 
mothers aged 17 years or less (O'Sullivan et al, 1992) focused on avoiding new 
pregnancies, completing the baby’s immunisation programme, and returning to 
school. The outcome common to all three trials was childhood immunisation; the 
infants in the intervention group were more likely to be fully immunised than were 
those in the control group, but a seven year follow-up in the Dublin study found no 
differences between the two groups (Johnson et al, 2000). There are potential 
economic advantages of applying the skills of experienced mothers living in the 
community, but the results were not robust enough to use as the basis for practice 
recommendations. Moreover there was no evidence of the cost-effectiveness of any 
of the interventions in a non-UK setting. 
 
Immunisation services for refugees, immigrants and migrant workers 
In a study in Western Sydney, 194 students who were refugees and migrant young 
people were surveyed and reported low immunisation rates. Those who were not 
immunised were offered immunisation for hepatitis B and MMR. As part of the 
school-based programme, 74% (142/194) received MMR vaccine. The study 
illustrates the health care needs of refugee and migrant young people in a high 
infection risk situation. It also illustrates the benefits of education and health working 
together (Milne et al, 2006). 
 
In Germany, a campaign to screen children of immigrants when they enrolled for 
school found that the children were poorly protected with MMR vaccination (Pallasch 
et al, 2005). Since they found that information events were not successful, they 
 41 
decided to train key people from within the groups to motivate the immigrant parents 
to take the children to the vaccination stations set up in the district (Pallasch et al, 
2005). 
 
SUMMARY OF REVIEW 
This review has identified from published research, a number of groups where 
coverage for MMR is likely to be lower, the contexts in which children are more likely 
to be partially immunised, those who are more likely to have a delay in immunisation, 
those who are likely to receive a single vaccine and those who are unlikely to 
immunise at all. 
 
The review has also identified interventions which may be effective in a primary care 
context and possibly cost-effective in a UK context, as well as some interventions 
which are unlikely to be effective. 
 
The review has identified some of the concerns and problems among primary care 
practitioners, specifically GPs, health visitors and practice nurses, all of whom are 
involved in the immunisation process with parents. 
 
Furthermore, the review has tapped into the rich information about why parents have 
concerns about immunising their infants and some of the reasons they choose not to 
immunise. 
 
We have made recommendations about what might be considered to maximise 
immunisation uptake, based on available evidence.  
 
We have also proposed measures which aim to address the concerns of health care 
practitioners and other measures to address the concerns of parents. However, there 
is no available evidence for these measures. 
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RECOMMENDATIONS 
Our recommendations are therefore as follows: 
 
1. Education for health care professionals should be a priority to address parental 
concerns, 
2. Practices should use a strategic approach to maximise uptake of immunisations,  
3. Practices should accurately record immunisation uptake, including single 
antigens, and use computers for identifying parents who need to be reminded,  
4. Practice should use a postal reminder, followed by a telephone call to parents, 
5. Practices should perform regular audit with feedback to all health care 
professionals involved in immunisations,  
6. Practices should consider collaborating with schools to plan ‘mop-up’ vaccination 
days. 
7. Practices should consider initiating interventions with regard to looked after 
children and refugees and immigrants. 
 
We strongly recommend that interventions which are newly introduced should be 
evaluated, ideally using a mixed methods approach, with a randomised controlled 
trial and qualitative evaluation, to capture evidence of an uptake of immunisation 
along with the perspectives of parents and health care practitioners. 
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Table 1: Results of review studies included  
Authors, 
Year 
Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Anderson et 
al, 1998 
 
Meta-
analysis.  
To perform a 
meta-analysis 
of office-
based 
interventions 
to determine 
their impact 
on three 
domains of 
preventive 
care: 
screening, 
immunisation, 
and 
counselling.  
Randomised 
controlled trials 
and non-
randomised 
controlled trials 
based in the 
USA, published 
in the English 
language to 
January 1997. 
Office-based 
interventions 
aimed at 
increasing 
provider 
performance in 
an ambulatory 
care setting, 
classified as 
feedback to 
providers, 
prompting to 
providers, 
prompting and 
ongoing 
monitoring. 
43 studies were 
included. 
14 were 
immunisation 
studies.  
Provider: Mean effect 
size for immunisation: 
weighted=0.18, 
unweighted=0.16. 
Patient: Mean effect 
size for immunisation: 
weighted=0.15, 
unweighted=0.13. 
“Office-based interventions 
deserve continued 
development and evaluation 
for enhancing the delivery of 
preventive services.” 
“Our findings also point to 
the need for multiple 
interventions.” 
Unable to draw conclusions 
about the long-term effects 
on provider adherence.  
Bordley et al, 
2000 
Systematic 
Review.  
To assess the 
effectiveness 
of audit and 
feedback 
(A&F) on 
immunisation 
delivery by 
health care 
professionals. 
Randomised 
controlled trials 
(RCTs), 
published 1966 -
1998 controlled 
before and after 
studies (CBA), 
interrupted time 
series (ITS) and 
simple before 
and after studies 
(BA). Studies 
had to include 
A&F.  
Included 
studies of 
universally 
recommended 
childhood or 
adult vaccines. 
A&F defined as 
any summary of 
clinical 
performance 
gathered over a 
defined period 
of time, 
presented to 
the health care 
provider after 
collection.  
Participants in 
the studies were 
children aged 12 
months to 9 
years or adults 
aged 50 or more. 
n=5 studies on 
childhood 
immunisation 
(DTP, Oral polio, 
MMR, Hib, 
pneumococcal, 
influenza). 1 
RCT, 2 ITS, 4 
BA. 10 studies on 
adult 
immunisation. 4 
RCTs, 6 BA or 
ITS. 
In general, the 
published studies 
assessing the impact 
of A&F on childhood 
immunisation rates 
demonstrate a positive 
association, although 
the number and quality 
of the studies identified 
was limited. Only 2 
studies examined the 
effect of A&F as the 
sole intervention and it 
is difficult to evaluate 
the independent effect 
of A&F and the 
magnitude of its effect 
on childhood 
immunisation rates.  
The evidence from published 
studies suggests that A&F 
alone may be an effective 
strategy for improving 
immunisation rates. The 
number of well-conducted 
studies is small and the 
effect is variable. 
 
Recommendations 
Additional well-designed 
studies are needed to 
identify the independent 
effects of A&F, optimal 
format and frequency of 
A&F, and to examine its long 
term effect on provide 
immunisation practices and 
costs.  
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Authors, 
Year 
Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Briss et al, 
2000 
Systematic 
review.  
A systematic 
review of the 
effectiveness, 
applicability, 
other effects, 
economic 
impact, and 
barriers to use 
of selected 
population-
based 
interventions 
intended to 
improve 
vaccination 
coverage.  
Primary studies 
published from 
1980 – 1997, in 
industrialised 
countries, 
comparing a 
group of people 
exposed to an 
intervention with 
a group who 
had not been 
exposed or who 
had been less 
exposed. 
Execution of 
studies was 
classified as 
good, fait or 
limited. Studies 
with limited 
execution did 
not qualify for 
the review.  
Interventions 
intended to 
improve routine 
delivery of 
universally 
recommended 
vaccinations. 
Total 183 
included studies. 
42 of 
reminder/recall 
interventions. 
17: 
multicomponent 
interventions that 
include 
education. 
9: vaccination 
requirements for 
child care, 
school, college 
attendance. 
1: community-
wide education. 
3: clinic-based 
intervention. 
3: client/family 
incentives. 
3: client held 
medical records. 
19: reducing out-
of-pocket costs. 
16: expanding 
access in health 
care settings. 
4: vaccination 
programmes in 
Women, Infant 
and Children 
(WIC) settings. 
7: home visits. 
1: schools 
vaccination 
programmes. 
⋅ Reminder/recall 
interventions – a 
median 8% change. 
Adjusted cost-
effectiveness ratios 
ranged from $4-£46 
per additional 
vaccination. 
⋅ Lower incidence of 
measles and mumps 
and more likely to have 
‘documented 
immunity’. 
⋅ Education 
interventions – a 
median 16% change in 
vaccination coverage. 
Costs range from 
$7.65 to $23 per 
vaccination delivered. 
⋅ Community-wide 
education – 
improvements in the 
number of measles 
vaccinations delivered 
in children aged 6 
years. 
⋅ Studies reducing out-
of-pocket costs found a 
median 15% change in 
coverage. 
⋅ Studies WIC settings 
showed a 4-34% 
improvement in 
vaccination coverage. 
⋅ Studies that 
evaluated 
⋅ Strong evidence exists that 
client reminder/recall is 
effective in improving 
vaccination coverage. 
⋅ Strong evidence exists that 
multicomponent interventions 
that include education are 
effective in improving 
vaccination coverage. 
⋅ Sufficient evidence exists 
that vaccination 
requirements for child care, 
school, and college 
attendance are effective in 
improving vaccination 
coverage and immunity and / 
or reducing rates of disease. 
⋅ Insufficient evidence of 
community-wide education in 
improving knowledge or 
attitudes or improving 
delivery of vaccinations. 
⋅ Insufficient evidence of 
clinic-based education in 
improving vaccination 
coverage. 
⋅ Insufficient evidence from 
incentives for improving 
vaccination coverage. 
⋅ Insufficient evidence to 
assess effective of client-
held records. 
⋅ Strong evidence that 
reducing out-of-pocket costs 
for vaccination is effective in 
improving vaccination 
coverage. 
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29: provider-
based reminder 
/recall 
interventions. 
14: assessment 
and feedback for 
vaccination 
providers. 
11: standing 
orders (non-
physicians deliver 
vaccinations 
without direct 
physician 
involvement). 
4: education only. 
reminder/recall only 
found a 17% median 
change in coverage. 
⋅ Studies of 
assessment and 
feedback for 
vaccination providers 
found a median 16% 
change in coverage.  
⋅ Strong evidence exists that 
expanding access as part of 
a multi-component 
intervention improves 
coverage among children 
and adults in a range of 
contexts. 
⋅ Sufficient evidence of 
effectiveness of interventions 
in WIC settings in improving 
vaccination coverage. 
⋅ Sufficient evidence exists 
that home visiting 
interventions are effective in 
improving vaccination 
coverage. 
⋅ Insufficient evidence to 
determine the effectiveness 
of school-based vaccination 
interventions. 
⋅ Strong evidence exists of 
the effectiveness of 
reminder/recall interventions. 
⋅ Strong evidence exists for 
the effectiveness of 
assessment and feedback 
for vaccination providers. 
⋅ Strong evidence that 
standing orders are effective 
for improving coverage in 
adults, but insufficient 
evidence of improvement in 
children. 
⋅ Insufficient evidence of the 
effectiveness of provider 
education in improving 
vaccination coverage due to 
few studies of limited design. 
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Table 1: Results of review studies included (continued) 
Authors, Year Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Elkan et al, 
2000 
Canada, 
England, 
Ireland, USA 
Systematic 
review.  
To conduct a 
systematic 
review of the 
effectiveness 
and cost-
effectiveness 
of home 
visiting by 
Health Visitors 
(HVs).  
Studies 
published 1980-
1997 including a 
comparison 
group, RCTS, 
non-RCTS, and 
controlled 
before and after 
comparisons.  
Home visiting 
programmes.  
102 studies 
evaluating 86 
home visiting 
programmes; 
11 reporting 
uptake of 
immunisation.  
Meta-analysis of the 
RCTs with comparable 
measurement of uptake 
produced an OR=1.67 
(95% CI, 1.29 to 2.15) 
and heterogeneity 
between treatment 
effects was significant 
(א2=16.6; 4df: p=0.002). 
Our review of the 
effectiveness of home visiting 
programmes suggests that 
they are not effective in 
increasing uptake of 
immunisation or uptake of 
other preventive child health 
services. 
Recommendations 
There is a need for more 
studies with rigorous 
experimental designs to 
evaluate the effectiveness of 
home visiting by British HVs 
and for further studies 
comparing the effectiveness 
and cost-effectiveness of 
professional and non-
professional home visitors. 
Giuffrida et al, 
1999 
Cochrane 
review.  
To evaluate 
the impact of 
target 
payments on 
the 
professional 
practice of 
primary care 
physicians 
(PCPs) and 
health care 
outcomes. 
Randomised 
trials, controlled 
before and after 
studies and 
interrupted time 
series analyses 
of interventions.  
Target 
payments to 
primary care 
professionals 
vs. alternative 
methods of 
payment, on 
patient 
outcomes, 
health services 
utilisation, 
health care 
costs, equity of 
care, and PCP 
satisfaction with 
working 
environment. 
Two studies 
were included 
involving 149 
practices. 
The use of target 
payments in the 
remuneration of PCPs 
was associated with 
improvements in 
immunisation rates, but 
the increase was 
statistically significant in 
only one of the two 
studies. 
Evidence from the studies in 
this review is not of sufficient 
quality or power to obtain a 
clear answer as to whether 
target payment remuneration 
provides a method of 
improving primary health 
care. Efforts should be 
directed in evaluating 
changes in remuneration 
systems. Although it would 
not be difficult to design a 
randomised controlled trial to 
evaluate the impact of such 
payment systems, it would be 
difficult politically to conduct 
such trials. 
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Table 1: Results of review studies included (continued) 
Authors, 
Year 
Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Gyorkos et 
al, 1994 
Literature 
Review.  
To review the 
effectiveness 
of 
immunisation 
delivery 
methods for 
influenza; 
pneumonia; 
hepatitis B; 
measles, 
mumps, and 
rubella 
(MMR); 
diphtheria, 
pertussis, 
tetanus and 
polio (DPTP). 
Randomised 
controlled trials, 
cohort studies, 
clinical trials, 
observational 
community 
studies, 
published from 
1979 to 
September 1992. 
Interventions 
were categorised 
as: client-
orientated, e.g. 
mailed reminders 
to patients); 
orientated to the 
provider, e.g. 
chart reminders 
to physicians; or 
system related, 
e.g. legislation. 
Where 
interventions 
were orientated 
to more than one 
group they were 
classified as 
mixed. 
Fifty-four 
articles in 
total: 24 
influenza, 
11 
pneumonia, 1 
hepatitis B, 
13 MMR and 
5 DPTP. 
Influenza. Total: pooled effect 
18.6% (95% CI: 17.7, 19.5). 
RCTs: pooled effect 12.9% 
(95% CI: 10.2, 15.7). 
Pneumococcal. Total: pooled 
effect 29.7% (95% CI: 24.9, 
34.5). 
Hepatitis B. 1 study was 
included, an RCT of weak 
internal validity. 
Increased coverage of target 
population: 
Mailing only: 1.9% (95% CI: -
4.1, 7.9). Mailing plus decision 
analysis: 6.3% (95% CI: 1.0, 
11.6). 
Childhood immunisations. 
MMR. Pooling of studies was 
not appropriate because of 
differences in, e.g. intervention 
and target population. 
Of 2 client-orientated studies, 
1 increased coverage by 62% 
(baseline 3.1%) and the other 
increased coverage by 5% 
(baseline 42%). 
System-orientated: studies 
were legislation, public versus 
private type of services and 
technical resources. 
Legislation had the biggest 
effect. 
Target population coverage: 
In school age children or older, 
all studies showed effects of 
44% or higher. In pre-school 
Influenza. Interventions for 
improving immunisation 
coverage have largest effect 
when aimed at hospital 
populations. Standing orders 
for vaccine in hospitals and 
clinics has a positive effect. A 
high response is achieved 
with personalised mailed 
reminders or health care 
practitioner-initiated 
telephone calls. Analysis of 
baseline coverage suggests a 
ceiling effect; studies having 
baselines of 50% or higher 
have significantly less 
improvement levels than 
others. 
Pneumococcal. Client- or 
system-orientated hospital 
interventions for high-risk 
patients can ensure high 
vaccination rates. 1 study 
found increased rates could 
be affected when the health 
department promotes and 
offers the vaccine. Lack of 
relevant studies especially in 
a community setting. Further 
research should be promoted 
to address feasibility, 
effectiveness and cost-
effectiveness. 
Hepatitis B. 1 study with 
limited applicability to general 
population so further research 
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children the effect ranged from 
-43.5 to 25%. 
A letter reminder had little 
effect (5%); legislation had a 
large effect (44%); and change 
in the immunisation schedule 
resulted in a decrease in 
coverage (-42%). 
DPTP. Inappropriate to 
calculate pooled effects 
because of small number of 
studies. Individual effects of 
interventions are presented. 
Feedback of immunisation 
practice: large effects (56.1%, 
95% CI: 42.2, 70.0), postcard 
reminders (33.9%, 95% CI: 
19.9, 48.0). Changing the 
timing of MMR vaccination 
from 12 to 15 months resulted 
in a decrease in coverage 
levels of the DPT booster at 
18 months. 
in this field is imperative. 
Primary immunisations 
(MMR and DPTP). Greater 
coverage rates found with 
system-orientated 
interventions than client-
orientated interventions. 
Computerisation, being 
served by a Health 
Maintenance organisation, 
and providing feedback on 
practice were all shown to 
result in increases in 
coverage. Changing the 
schedule of DPT vaccine 
administration from 12 to 15 
months resulted in a 
decrease in coverage. 
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Table 1: Results of review studies included (continued) 
Authors, 
Year 
Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Jacobson 
Vann et al, 
2005 
Cochrane 
review.  
To assess 
the 
effectiveness 
of patient 
reminder and 
recall 
systems in 
improving 
immunization 
rates, and 
compare the 
effects of 
various types 
of reminders 
in different 
settings or 
patient 
populations. 
Randomized 
controlled trials 
(RCT), controlled 
before and after 
studies (CBA), 
and interrupted 
time series (ITS) 
studies written in 
English published 
from 1966 to 
1998.  
Any intervention 
that falls within 
the EPOC scope 
and that includes 
patient reminder 
or recall systems, 
or both, in at 
least 1 arm of the 
study. Health 
care personnel 
who deliver 
immunisation and 
children (birth to 
18 years) or 
adults (18 years 
and up) who 
receive 
immunisation in 
any setting.  
Four new 
studies were 
added for the 
2007 update 
for a total of 
47 studies. 
Data were 
reported as 
odds ratios 
(Ors) for 
being up to 
date or 
having 
received 
vaccinations 
as 
recommende
d if one 
received a 
reminder. 
Reminders effective for 
childhood vaccinations (OR = 
1.47, 95% CI =1.28, 1.68), 
childhood influenza 
vaccinations (OR = 2.18, 95% 
CI = 1.29, 3.70), adult 
pneumococcus, tetanus, and 
Hepatitis B (OR = 2.19, 
95%CI = 1.21, 3.99), and 
adult influenza vaccinations 
(OR = 1.66, 95% CI = 1.31, 
2.09). The effectiveness of 
patient reminders for 
childhood influenza 
vaccinations declined overall 
from an odds ratio of 2.87 in 
the previous review. 
Reminders were not effective 
in the 1 new study of 
adolescent immunizations in 
an urban setting (OR = 1.14, 
95% CI = 0.98, 1.31). All 
types of reminders were 
effective (postcards, letters, 
telephone or autodialer calls), 
with telephone being the most 
effective but also the most 
costly. 
Patient reminder and recall 
systems in primary care 
settings are effective in 
improving immunization 
rates in developed 
countries. 
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Table 1: Results of review studies included (continued) 
Authors, 
Year 
Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Kendrick 
et al, 
2000 
Systematic 
review and 
meta-
analysis. 
To evaluate the 
effectiveness of 
home visiting 
programmes on 
the uptake of 
childhood 
immunisation. 
Empirical studies 
with control 
groups. 
Studies had to 
report 
immunisation 
outcomes 
relevant to British 
health visiting 
with parents of 
infants due to 
receive childhood 
immunisations. 
Eleven controlled 
studies were 
included. Two 
studies not 
included in the 
analyses as did 
not provide 
outcome 
measures that 
permitted 
pooling; one 
reported positive 
outcomes. 
Uptake of immunisations (n=9). 
Pooled odds ratio (OR) 1.17 
(95% CI: 0.33-4.17). Significant 
heterogeneity between studies 
(chi-squared = 22.1, p<0.005). 
The review has failed to 
demonstrate a beneficial 
effect of home visiting on 
uptake of immunisation. 
Other methods of increasing 
uptake and reducing 
inequalities in uptake will 
need to be explored. 
Lewin et 
al, 2005 
Cochrane 
review. 
To assess the 
effects of LHW 
interventions in 
primary and 
community health 
care on health 
care behaviours, 
patients' health 
and wellbeing, 
and patients' 
satisfaction with 
care. 
Randomised 
controlled trials of 
any intervention 
delivered by 'lay 
health workers' 
(paid or voluntary) 
in primary or 
community health 
care and intended 
to promote health, 
manage illness or 
provide support to 
patients.  
A 'lay health 
worker' (LHWs) 
defined as any 
health worker 
carrying out 
functions related 
to health care 
delivery; and 
having no formal 
professional or 
paraprofessional 
education. 
43 studies. 
210,110 
consumers. 
Diversity in the 
aims, content and 
outcomes of 
interventions. 
Most in high 
income countries 
(n=35), nearly half 
of these focused 
on low income 
and minority 
populations 
(n=15). 
Promising benefits in 
comparison with usual care 
were shown for LHW 
interventions to promote 
immunisation uptake in 
children and adults (RR=1.30 
[95% CI 1.14, 1.48] p=0.0001) 
and LHW interventions to 
improve outcomes for selected 
infectious diseases (RR=0.74 
[95% CI 0.58, 0.93) p=0.01). 
LHWs show promising 
benefits in promoting 
immunisation uptake and 
improving outcomes for acute 
respiratory infections and 
malaria, when compared to 
usual care. There is also 
insufficient evidence to 
assess which LHW training or 
intervention strategies are 
likely to be most effective. 
Further research is needed in 
these areas. 
Roberts 
et al, 
2002 
Bayesian 
synthesis of 
qualitative 
and 
quantitative 
evidence. 
To explore the 
feasibility and 
value of synthesis 
of qualitative and 
quantitative 
evidence of 
uptake of 
immunisation. 
11 qualitative and 
32 quantitative 
studies of factors 
affecting uptake of 
childhood 
immunisation 
published from 
1970 – July 1999. 
Any factor that 
affected the 
uptake of 
childhood 
immunisation in 
developed 
countries. 
43 published 
studies. 
Lay beliefs, advice from health 
professional, Child’s health 
history, Structural issues, 
Social position, Forgetting, 
Religious / moral beliefs, Role 
of parent, Postnatal period, 
Media representation. Type 
and pattern of service used. 
Qualitative or quantitative 
research alone may not 
identify all factors, or result in 
inappropriate judgements and 
formulation of evidence-
based policy. 
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Table 1: Results of review studies included (continued) 
Authors, 
Year 
Design / 
Method 
Aim Study designs 
and dates  
Interventions Data Results  Authors’ conclusions 
Sullivan & 
Mitchell, 
1995 
Systematic 
review of 
world reports. 
To review 
findings from 
studies of the 
influence of 
desktop 
computers on 
primary care 
consultations. 
1984 to 1994. 30 evaluations 
of computers in 
primary care. 6 
examined the 
effects on the 
consultation 
process. 
21 evaluated 
effects on 
clinicians' 
performance of 
tasks. 
3 measured the 
impact on 
patient 
outcome. 
The emphasis 
was on 
immunisation and 
other preventive 
tasks (n=14) and 
on prescribing 
(n=4), fewer 
studies being 
concerned with 
the management 
of disease. 
Immunisation rates for 
tetanus and influenza 
improved by 8-18% and 
other preventive tasks 
performed improved by 
up to 50%. 
Use of a computer during 
consultations improves 
immunisation rates by 8-18% 
and other preventive tasks by 
up to 50%. Future research 
should centre on outcomes of 
care for patient. Need to look 
at new methods of evaluating 
these major changes in "the 
essential unit of medical 
practice”. 
Whittaker, 
2002 
Review. To identify 
whether the 
involvement of 
lay workers in 
community 
child health 
services is 
effective in 
improving the 
uptake of 
childhood 
immunisation.  
Randomised 
controlled trials 
published from 
1993 – 2000. 
Studies 
involving 
support to 
parents 
comparing 
conventional 
child health 
services with 
involvement of 
lay or non-
professional 
workers, 
conducted in 
economically 
deprived 
communities.  
1. n=267 first 
time mothers in 
Ireland. 
2. n=163 parents 
of children under 
2 years of age 
from a New York 
immigrant 
community from 
the Dominican 
Republic. 
1. 85% Intervention 
group children vs. 65% 
control completed 
primary immunisations 
by their 1st birthday (RR 
1.31, 95% CI 1.21 to 
1.54, p<0.001). 
2. 75% intervention 
group vs. 54% control 
were up to date with 
immunisation (RR 2.8, 
95% CI 1.21 to 6.54, 
p<0.05). 
⋅ Lay support can be 
effective in increasing the 
uptake of vaccination. 
⋅ Equally, intervention effects 
could, because of differing 
cultural and 
sociodemographic factors, 
could be less marked when 
applied to British populations, 
in which the parents of pre-
school-aged children have 
access to immunization 
support from a generic health 
visiting service. 
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Table 2: Results of intervention studies included 
Authors, year, 
Place 
Design / 
Method 
Aim Intervention  Participants Results Authors’ Conclusions  
Conway et al, 
1999 
Leeds, 
England  
Before and 
after study. 
To assess the 
potential for 
administering 
catch-up and 
scheduled 
immunisation 
during hospital 
admission. 
Junior doctors 
instructed to offer 
appropriate 
vaccination before 
discharge. 
Consultants asked 
to reinforce this 
proactive policy on 
ward rounds.  
Carers of 
n=1000 
consecutive 
preschool age 
children. 
789/1000 (78.9%) had 
been immunised. 
142 (14.2% had missed 
an age-appropriate 
immunisation. 
41 were due a scheduled 
immunisation. 
43/183 (23%) were 
offered vaccination. 
28/183 (15%) accepted.  
⋅ Admission to hospital provides 
opportunities for catch up and 
routine immunisation. This can 
contribute to the health care of an 
often disadvantaged group. 
⋅ Junior doctors must be 
encouraged to see opportunistic 
immunisation as part of their routine 
work. 
Joyce-Cooney 
et al, 2003 
Longford, 
Ireland  
Before and 
after study. 
To document 
uptake rates 
achieved for 
vaccinations 
administered in 
a school 
immunisation 
programme in a 
school year.  
Information packs 
delivered by 
schools to parents 
(letter, leaflets, 
consent form). Area 
medical officer 
gave explanatory 
talk. Issues 
discussed in 
private. Phonecall 
follow-up of non-
attenders.  
Parents of 
MMR=6436 
school children 
in 115 schools.  
140 vaccinations 
opportunistically 
administered. 
Uptake rates of 94.7% for 
MMR and over 95% were 
achieved for all the 
vaccines in the 
programme. 
⋅ The programme’s success was 
due: to a dedicated team, relieved 
of all other responsibilities, which 
facilitated the active follow-up of all 
defaulters as identified by the clear 
comprehensive database made 
available to schools; the availability 
of telephone numbers; and a 
dedicated telephone line. 
Avoidance of deferral for minor 
illness was also a key factor, as 
children well enough to be in school 
were considered to be well enough 
for vaccination.  
Margolis, et al, 
2004 
North Carolina 
USA 
Randomised 
trial in 
primary care. 
To examine 
effectiveness of 
“office systems” 
to improve the 
delivery of 
preventive care 
(including 
immunisation) 
to children.  
Practice based 
continuing medical 
education. Project 
staff coached 
practice staff to 
review, perform, 
identify, test, and 
implement new 
care processes 
(e.g. chart) to 
improve delivery of 
preventive care.  
Random 
sample of 44 
private 
paediatric and 
family practices 
allocated to 
intervention or 
control group.  
Intention to treat analysis. 
Proportion of children per 
practice with age-
appropriate delivery of all 
4 preventive services (4 
scheduled injections of 
DTP, polio, MMR, 3 Hib, 
3 HepB by 24 months) 
changed after 1 year of 
implementation - 7% to 
34% in intervention. 9% 
to 10% in control.  
⋅ Continuing education combined 
with process improvement is 
effective in increasing rates of 
delivery of preventive care to 
children.  
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Table 2: Results of intervention studies included (continued) 
Authors, year, 
Place 
Design / 
Method 
Aim Intervention  Participants Results Authors’ Conclusions  
Mason & 
Donnelly, 2000 
Lechyd 
Morgannwg 
Health 
Wales 
Randomised 
controlled 
trial, with 
allocation 
using 
computer 
generated 
random 
letters. 
Sample size 
calculation 
estimated 
219 
participants 
per group 
were 
required.  
To investigate 
the effect on 
vaccine uptake 
of posting the 
MMR – The 
facts leaflet to 
parents of 
children who 
had not 
received MMR 
vaccine by 21 
months of age.  
Computerised child 
health record system 
used to generate a 
monthly list of parents 
Randomly selected 
parents in the 
intervention group 
were sent a personal 
reminder letter and 
leaflet. Control group 
parents had usual 
care (no action).  
Parents of 
children who had 
not received MMR 
vaccine by 21 
months of age. 
511 were 
recruited, 255 to 
intervention group 
and 256 to control 
group.  
12/255 children (4.7%) had 
already been immunised. In 
the intervention group, 7.2% 
(18/249) vs. 6.1% (15/244) 
in the control group (95% 
CI, -3.5 to 5.5). 
⋅ The data recorded on the child 
health system underestimated 
uptake by 4.8%. 
⋅ More complex intervention is 
required to influence the 
immunisation behaviour of parents. 
⋅ Interventions from health care 
professionals known to the parents 
might be more effective than 
interventions fro health authorities.  
Morgan & 
Evans, 1998, 
Cardiff 
Wales 
Randomised 
controlled 
trial. Weekly 
computer 
generated 
lists of 
children were 
randomised 
using 
computer-
generated 
numbers, to 
one of two 
interventions 
or control 
group.  
To examine the 
effectiveness of 
two contrasting 
interventions; 
HV or mail 
follow-up.  
Intervention A. a non-
directive phone call to 
the child’s HV to 
confirm the child’s 
detail and 
immunisation status. 
The HV was not 
informed of the trial. 
Intervention B. was a 
single mailed 
reminder to the child’s 
parent together with a 
questionnaire about 
reasons for non-
immunisation. The 
parents were also not 
informed about the 
trial. 
451 children 
resident in the 
former county of 
South Glamorgan, 
born 1 April – 30 
September 1995, 
who had not 
completed the 
primary course of 
DTP and Hib by 9 
months OR born 1 
April – 30 
September 1994 
who had not 
completed MMR 
by 21 months.  
Intention to treat analysis. 
Four groups: 
DTP, HV, 
2. MMR, HV, 
3. DTP, letter, 
4. MMR, letter. 
Examining DTP by 1st 
birthday and MMR by 
second birthday, there was 
no significant difference 
between any of the groups.  
⋅  
⋅  
⋅ “District-wide initiatives directed at 
individual families are unlikely to be 
worthwhile, although there may be 
some benefit from targeting young 
or primiparous mothers.” 
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Table 2: Results of intervention studies included (continued) 
Authors, year, 
Place 
Design / 
Method 
Aim Intervention  Participants Results Authors’ Conclusions  
Porter-Jones et 
al, 2008 
Flintshire 
Wales 
 
Pragmatic 
randomised 
controlled 
trial. Sample 
size 
calculation 
estimated 
469 
participants 
would be 
needed to 
achieve 80% 
power to 
detect a 7% 
difference at 
p<0.05). 
To examine a 
low-cost simple 
attempt to 
improve MMR 
uptake.  
Issue of teddy bears 
wearing T-shirts 
displaying a website 
address and 
telephone number 
that provided 
information re MMR 
vs. standard MMR 
information to all 
parents.  
994 children. 
432 received 
standard MMR 
information alone. 
542 received a 
teddy bear.  
87.3% intervention group 
received MMR vs. 88% 
control group. 
No calls were made to the 
telephone helpline. 
62 people accessed the 
website. 
86.1% males vs. 89.2% 
females were immunised 
(p=0.143). 
90.2% first-borns vs. 85.8% 
others were immunised 
(p=0.041). 
⋅ This method of promoting sources 
of information about MMR 
vaccination does not appear to 
have influenced MMR uptake. Most 
parents were not interested in using 
a website. 
⋅ Possibly too few parents had 
internet access. 
⋅ Calls out of office hours may have 
been missed.  
Wallace et al, 
2005 
Australia and 
New Zealand.  
Before and 
after study. 
To determine 
whether an 
evidence based 
decision aid on 
the MMR 
vaccine 
changed 
parents’ 
attitudes 
towards 
vaccination. 
Evidence based 
decision aid with text 
and graphical 
representation of the 
possible outcomes of 
measles, mumps and 
rubella diseases 
compared with MMR 
vaccination.  
Of n=1277 people 
accessed a 
website, n=158 
completed online 
questions. 
55% participants were 
‘leaning towards’ 
vaccination after using the 
decision aid than before, 
39%, (p<0.001). 
⋅ A web based decision aid 
significantly improved parental 
attitudes to MMR vaccination. 
Residual concerns about autism 
and bowel disease and the rare 
chance of serious complications 
remained as attitudinal barriers to 
some parents. 
⋅ Of interest would be whether the 
aid improved the timeliness and 
completion of MMR vaccine among 
children of parents concerned about 
the vaccine safety. 
⋅ Note: of the 158 people who used 
the aid, 62 (39% supplied 
demographic details and 52 (84%) 
were parents of children of 
vaccination age, and 39 had a 
university degree, indicating the 
possibility of respondent bias. 
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Table 2: Results of intervention studies included (continued) 
Authors, year, 
Place 
Design / 
Method 
Aim Intervention  Participants Results Authors’ Conclusions  
Wroe, et al, 
2005 
Auckland 
New Zealand 
 
Controlled 
study. 
Allocation to 
group 
unclear. 
To investigate 
the impact of an 
intervention that 
includes: a) The 
provision of 
more detailed 
information on 
the benefits and 
risk of 
immunisations 
according to 
scientific 
evidence, b) 
information on 
the possible 
role of 
emotional 
factors, and c) 
the focusing 
procedure. 
A4 size, 20-page 
booklet “Deciding 
about immunisation: 
the benefits and the 
risks.” plus 
information on the 
possible role of 
emotions, such as 
anticipated regret, 
information on ‘the 
golden rule’ and that 
immunising or not are 
both ‘active 
decisions’. 
The control group was 
sent an A5-size 19 
page booklet 
published by the 
Ministry of Health, 
“Immunisation 
Choices.” 
 
99/135 women 
attending one of 
10 hospital 
antenatal classes. 
Classes were 
alternately 
assigned. 
There was a greater 
difference between pre-
experimental ratings and 
post-experimental ratings of 
the likelihood of immunising 
in the intervention group 
than the control group. Post-
experimental ratings were 
significant higher in the 
intervention group than the 
control group 
(difference=11.81, 95% CI 
5.37 to 18.25). Participants’ 
decisions to immunise were 
strongly predicted by their 
antenatal likelihood of 
immunising ratings. In the 
intervention group 45 (90%) 
immunised the infant on 
time vs. 35 (70%) in the 
control group.  
⋅ An antenatal decision aid may 
benefit in overcoming the problem 
of low immunisation uptake. The 
study highlights the ability to 
successfully intervene antenatally. 
⋅ No single factor could be 
associated with the outcome as a 
‘package’ was delivered. 
⋅ The sample size was small, there 
may have been selection bias and 
the participants were not 
individually randomised. 
⋅ The study may be culturally 
specific (New Zealand). 
⋅ Replication in another country 
would investigate the 
generalisability of the findings.  
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Table 3: Results of economic evaluations included 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Study 
population 
Interventions Data Results  Authors’ conclusions 
Beutels 
et al, 
1996 
Germany  
Cost-
effectiveness 
analysis of 
routine varicella 
vaccination 
strategies. Non-
randomised 
study with 
historical 
controls and 1-
year post 
vaccination 
follow-up.  
To compare 
the cost-
effectiveness 
of three 
strategies: 
1. ‘Children 
strategy’ 
2. ‘Adolescent 
strategy’ 
3. ‘Children 
including 
catch-up’ 
strategy’. 
A hypothetical 
cohort of healthy 
children aged 
12-18 months 
and 12-year-olds 
with a negative 
history of 
varicella 
infection 
(excluding 
immunodeficient 
patients and 
those with 
cancer). 
Sample 
comprised 82 
vaccinated 
children and an 
unvaccinated 
control.  
1. Vaccination of 
all 12-18 month 
old children 
2. Vaccination of 
susceptible 12-
year olds 
3. Combination 
of strategy 1 and 
vaccination for 
11 years of 
susceptible 12-
year olds. 
Comparator 
used ‘no 
vaccination’ (as 
standard 
practice due to 
the general 
mildness of 
infection in 
healthy children.  
1991 and 1994 
US data and 
reports, costs 
derived from 
1986 and 1991-
94 studies 
adjusted to 
1995. 1995 
prices were 
used, in 
German Marks 
(DM). 
The attack rate was 
12% in the intervention 
group, vs. 86% in the 
control group. 
57% infections 
prevented using the 
‘children’ and 37% the 
‘adolescent’ strategies. 
20-35% deaths 
prevented. 
175 ‘adolescent’, 
401 ‘children’ and 
576 ‘Children including 
catch-up’ strategy’ life-
years gained. 
The adolescent strategy 
resulted in cost savings.  
From a societal 
perspective, the optimal 
feasible varicella 
prevention strategy is to 
vaccinate 15-month old 
children, use catch-up 
vaccination of 12-year 
olds for 11 years and 
from the 12th year 
onwards, continue to 
routinely immunise 15-
month old children. 
The validity of the 
conclusions depends on 
the integration of the 
programme into the 
current MMR 
programme in Germany 
and on its full public 
provision. 
The results may be 
applicable to other 
European countries.  
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Table 3: Results of economic evaluations included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Study 
population 
Interventions Data Results  Authors’ conclusions 
Dini et al, 
2000 
Denver, 
Colorado, 
USA 
Cost-
effectiveness 
analysis. 
1227 
children 
randomised 
into one of 
four groups 
with 22-
month 
follow-up. 
Primary 
outcome 
was series 
completion 
at 24 months 
of age.  
To assess the 
sustained 
impact during 
the first two 
years of life, 
and cost-
effectiveness 
of three types 
of computer-
generated 
reminder/recal
l messages 
(A. phone and 
letter, B. 
phone only, 
and C. letter 
only), 
compared 
with D. no 
notification.  
Children aged 
60-90 days who 
had received 1st 
dose of DTP or 
PV vaccines, 
and had 
telephone 
numbers in pre-
existing 
computerised 
health 
department 
database.  
Three types of 
computer-
generated 
reminder/recall 
messages sent 
to the families of 
children aged 
60-90 days who 
had received the 
first dose of DTP 
or PV vaccines.  
Evidence and 
resource use 
data 
corresponded to 
the period 1993-
1996. Prices 
were in US 
Dollars. 
Intention to treat 
analysis as well as 
treatment completers 
only. 
Most parents were 
positive about the phone 
contact. 
49.2% intervention 
group vs. 40.9% control 
group completed the 
immunisation series by 
24 months. 
50.2% in group A. 
phone and letter. 
After discounting start-
up costs, the cost for 
each additional child 
completing the 
immunisation series was 
$46 at 18 months and 
$79 by 24 months. 
B. phone only, and 
C. letter only. 
⋅ The study suggests 
that vaccine coverage of 
pre-school children can 
be increased by 
repeated use of 
automated parent 
notifications during the 
1st 2 years of a child’s 
life. 
⋅ The cost results may 
not be generalisable 
outside the study 
setting. 
⋅ Further studies need 
to define the cost-
effectiveness of 
computer-generated 
messages and 
determine the optimal 
number and sequence. 
⋅ Note: significant 
ethnic and language 
differences between 
groups.  
Franzini et 
al, 2000 
Houston 
Texas 
USA 
Cost-
effectiveness 
analysis. 
Case control 
study, each 
site 
randomly 
allocated to 
one of the 
study arms. 
1130 
To assess the 
cost-
effectiveness 
of different 
immunisation 
reminder/recal
l systems on 
return visits 
and 
immunisation 
coverage with 
1130 children 
under one year 
of age, and 
undergoing their 
1st, 2nd or 3rd 
DTP vaccine of 
DTaP vaccine. 
A postcard sent 
7 days before 
the target date 
for a return visit 
vs. a phone 
contact 
(autodialer) with 
a computer 
automated 
message sent 7 
days before the 
Data on 
effectiveness 
and resource 
use were 
gathered from 
may 1997 to 
April 1998. 
Prices were in 
US dollars. 
350 returned in the mail 
group, 292 in the 
autodialer group and 
287 in the control group. 
The additional number 
of immunised children 
relative to control group 
was 161 in the mail, 
group and 224 in the 
autodialer group. 
The cost perspective 
⋅ The system based on 
the autodialer was the 
most effective in return 
visits and 
immunisations. 
⋅ The analysis 
supported the use of a 
recall system based on 
autodialer, in small 
private physicians’ 
offices, especially in 
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children 
presenting at 
one of 6 
study 
centres. 
no reminders. target date for a 
return visit, vs. 
no reminding. 
was that of the provider 
of immunisation 
services. 
The cost per child was 
higher in the mail group 
than in the autodialer 
group in all cost 
analyses. 
conjunction with a fully 
operational 
immunisation registry. 
Since start-up costs 
were quite high, the 
autodialer system 
appeared more cost-
effectiveness in large 
patient populations. 
Germann & 
Matter, 1991 
Bern, 
Switzerland 
Cost-
effectiveness 
analysis. 
Prospective 
cohort study 
in one 
centre.  
To assess the 
cost-
effectiveness 
of two 
different 
strategies, 1. 
Determination 
of immunity 
followed by 
MMR 
vaccination, 
2. Universal 
MMR 
immunisation. 
To document 
the proportion 
of students 
not 
immunised 
and any 
increase in 
vaccination 
rate.  
816 3rd year 
male and female 
medical students 
on a 5-year 
course.  
Vaccination of 
medical students 
against measles, 
mumps and 
rubella using 
either the 
immunisation of 
non-immune 
students or a 
universal 
immunisation 
programme. 
Effectiveness 
data were 
based on the 
authors’ opinion 
and resource 
use was 
estimated using 
data for 1994-
1997. Prices 
were in Swiss 
Francs.  
Intention to treat 
principle. Primary health 
outcome was the 
immunisation rate. 
The screen and 
vaccinate programme 
achieved a greater than 
95% immunisation level. 
82/87 (94.3%) of 
students who were 
identified by the 
screening process as 
non-immune were 
vaccinated. 
Screening costs were 
only 80% of the total 
costs. Screening and 
vaccination was more 
cost-effectiveness at an 
immunity rate of 73.5%.  
⋅ A targeted programme 
of MMR vaccination was 
successful in increasing 
the immunisation rate of 
medical students 
against MMR to more 
than 96%. The cost 
results may not be 
generalisable outside 
Switzerland.  
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Table 3: Results of economic evaluations included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Study 
population 
Interventions Data Results  Authors’ conclusions 
Lieu et al, 
1997 
Oakland, 
California 
USA 
Cost-
effectiveness 
analysis.  
To estimate 
the cost-
effectiveness 
of sending a 
computer-
generated 
recall letter to 
parents of 
children with 
overdue MMR 
immunisation 
compared 
with sending 
no reminders. 
Parents 
randomised 
by random 
generator to 
receive a 
recall letter 
(intervention) 
or no letter 
(control 
group). 
Parents of a 
hypothetical 
cohort of 
children aged 20 
months who 
have not yet had 
their MMR 
immunisation 
and were 
members of the 
Kaiser 
Permanente 
facilities in North 
Carolina, 
followed-up to 
age 24 months. 
A computer-
generated recall 
letter to parents 
of children with 
overdue MMR 
immunisation. 
Effective and 
resource data 
related to 
19994. Prices 
were in US 
dollars at 1996 
prices. 
Intention to treat 
analysis. Primary 
outcome the number of 
children not vaccinated 
by 24 months. 
54% of letter group 
received MMR by vs. 
35% control group 
(p=0.001). Intervention 
would result in an 
additional 4% of the 
population receiving 
immunisation. The cost-
effectiveness ratio for 
the intervention was 
$4.04 per child 
appropriately immunised 
in 1996 prices.  
⋅ The use of computer 
generated recall letters 
to privately insured 
families with 
underimmunised 
children of 20 months of 
age improved 
immunisation delivery 
compared with families 
who were not sent a 
recall letter. It was not 
clear if this was the 
most cost-effective 
strategy.  
Lieu et al, 
1998 
Northern 
California 
USA 
Cost-
effectiveness 
analysis. 
Randomised 
controlled trial 
using the 
Kaiser 
Permanente 
immunisation 
tracking 
system.  
To evaluate 
the cost-
effectiveness 
of 4 
interventions: 
1. automated 
phone 
message, 
2. a letter, 
3. automated 
phone 
752 
underimmunised 
children aged 20 
months.  
Sending letters, 
automated 
phone messages 
of both to 
families with 
underimmunised 
children aged 20 
months to 
improve 
immunisation 
rates.  
Effectiveness 
and resource 
use data were 
obtained from 
September 
1996 to January 
1997. The price 
year was 1997. 
Prices were in 
US Dollars.  
The percentages of 
underimmunised 
children who received 
any needed vaccination 
were: 
⋅ 44.2% (95% CI, 36.6 
– 51.9) for phone, 
⋅ 43.8% (95% CI, 36.1 
– 51.5) for letter, 
⋅ 53.3% (95% CI, 45.7 
– 60.9) for phone - 
⋅ A letter followed by 
telephone call was the 
most effective option to 
improve the 
immunisation rates 
among underimmunised 
children. Letters 
followed by phone 
messages were more 
cost-effective than either 
type of message alone. 
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message 
followed by a 
letter, 
4. A letter 
followed by an 
automated 
phone 
message.  
letter, 
⋅ 57.8% (95% CI, 49.9 
– 65.7) for letter – 
phone. The results for 
letter-phone were 
statistically 
significantly from the 
groups receiving a 
single message 
(p<0.05). relative to no 
intervention, the cost 
per child immunised 
by 24 months of age 
was $9.80 for phone, 
⋅ $10.50 for letter, 
⋅ $7.00 for phone - 
letter, 
⋅ For adding letters to 
an existing phone 
strategy, the 
incremental cost-
effectiveness would 
be $8.30 per child 
immunised. 
Smith & 
Roberts, 
2000 
Pittsburgh, 
USA. 
Cost-utility 
analysis.  
To estimate 
the cost-
effectiveness 
of varicella 
vaccination 
strategies for 
adults in the 
USA with no 
history to 
chickenpox. 
Hypothetical 
cohort of 20-29 
year olds or 30-
year old and 
older adults.  
Varicella testing 
then vaccination, 
No testing and 
vaccinating all, 
Vs. No 
vaccination. 
Effectiveness 
data derived 
from 6 studies 
published in 
1978 and 1992. 
Prices and 
resources 
derived from 
websites 
accessed in 
1998. Prices 
were in US 
dollars.  
For those aged 20-29, 
varicella testing then 
vaccination generated 
16.6 quality-adjusted 
hours and the 
vaccination all strategy 
generated 0.17 quality-
adjusted life hours. 
Incremental costs were 
lower for the varicella 
testing then vaccination 
strategy. The preferred 
strategy was dependant 
on the probability of 
immunity level, the costs 
⋅ Varicella testing 
followed by vaccination 
of adults aged 20-29 
years in the USA may 
be cost-effective relative 
to conventional criteria 
among those motivated 
to complete the 
vaccination protocol. In 
older adults, testing is 
expensive compared 
with accepted 
interventions for other 
medical conditions. 
However, varicella 
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of the immunity test and 
the cost of the vaccine. 
antibody testing and 
vaccination may be 
cost-effective for adults 
of any age who are 
unlikely to have 
immunity, or who have a 
greater risk of 
developing chickenpox 
or its complications.  
Terada et 
al, 2000 
Okayama 
Japan 
Cost-
effectiveness 
analysis.  
To examine 
the cost-
effectiveness 
of double 
vaccination 
programmes 
for rubella, 
from the 
perspective of 
the Japanese 
health care 
system. 
Japanese 
children in the 
community aged 
1-3 years for the 
first rubella 
vaccination and 
6-9 years for the 
second 
vaccination.  
Programme 1. 
1st vaccination 
administered 
individually aged 
1-3 and 2nd 
vaccination 
administered 
individually aged 
6-9. 
Programme 2. 
1st vaccination 
administered 
individually then 
2nd administered 
as part of a 
primary school 
vaccination 
programme. 
Programme 3. 
1st vaccination 
administered 
individually, but 
2nd vaccination 
administered 
based on the 
results of an 
annual urine test 
in primary 
school. 
Effectiveness 
data derived 
from studies 
published in 
Japan from 
1997 – 2000. 
Prices were in 
Japanese yen. 
The vaccination success 
rate was 95%. 
The school rubella 
vaccination coverage 
rate was 70%. 
The school urine teat 
coverage rate was 97%.  
⋅ Programme 3 where 
the 1st vaccination was 
administered on an 
individual basis aged 1-
3 and the 2nd 
vaccination based on 
the results of a urine 
test at primary school 
was the most effective 
strategy in improving the 
positive rate of rubella 
antibody detection 
However, it was the 
most costly programme, 
but sensitive to the cost 
of urine antibody testing.  
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Table 3: Results of economic evaluations included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Study 
population 
Interventions Data Results  Authors’ conclusions 
Watson 
et al, 
1996 
Portland, 
Oregon, 
USA. 
Cost-
effectiveness 
analysis and 
measles 
seroprevalence 
study on a 
cohort of 
children 
followed-up for 
12-33 days 
(median 14). 
To assess the 
efficiency of 
routinely 
vaccinating (2-
dose schedule) 
children aged 4-
6 years against 
measles.  
679/ 2305 invited 
parents of 
children aged 4-
6 years who had 
received 1 dose 
of measles 
vaccine aged 15-
17 months, who 
had never been 
diagnosed as 
having cancer, 
leukaemia, or a 
serious defect of 
the immune 
system. 
Initial antibody 
testing for 
measles 
followed by 
revaccination 
and antibody 
testing of those 
who were 
seronegative.  
The 
effectiveness 
data 
corresponded to 
1990. 
37 children were measles 
seronegative and were 
re-vaccinated and 36 
(97%) responded by 
seroconversion. Maternal 
education was the only 
factor associated with 
non-response to initial 
vaccination. Of 679 
children re-vaccinated, an 
additional 36 (5%) 
seroconversions were 
achieved relative to the 
initial vaccination option.  
⋅ Revaccination 
substantially reduces 
the pool of susceptible 
children. The cost of 
seroconversion was 
high at $415. A two 
dose schedule should 
significant reduce the 
risk and impact of 
outbreaks of measles 
in vaccinated cohorts. 
⋅ Further studies are 
needed to validly state 
the cost and 
effectiveness of 
measles revaccination 
relative to initial 
vaccination alone.  
White et 
al, 1985. 
USA 
Cost-
effectiveness 
analysis. 
Epidemiological 
cohort model of 
survival and 
disease. 
To compare 
1. MMR vaccine 
with no 
immunisation 
programme, 
2. MMR vaccine 
with vaccination 
using separate 
measles, mumps 
and rubella 
antigens, 
3. Separate 
measles, mumps 
and rubella 
antigens with no 
immunisation 
programme.  
All infants in the 
United States.  
1. MMR vaccine 
2. Measles, 
mumps and 
rubella as 
separate 
vaccines.  
Direct costs 
were to the 
health service 
and the patient 
with price 
information 
related to 1983. 
The cost-benefit ratio was 
14.4: 1 for MMR vaccine 
vs. no immunisation 
programme. 
The cost-benefit ratio was 
8.9: 1 for separate 
measles, mumps and 
rubella vaccines vs. no 
immunisation 
programme. 
For MMR vaccine vs. 
measles, mumps and 
rubella separate 
vaccines, the incremental 
cost was negative and 
benefits were zero. 
 
⋅ The combined 
vaccine programme 
dominated the 
individual vaccines, 
assuming equivalence, 
but lower costs. 
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Table 3: Results of economic evaluations included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Study 
population 
Interventions Data Results  Authors’ 
conclusions 
Zhou et 
al, 2001 
USA 
Cost-benefit 
analysis. 
To investigate 
the costs and 
benefits of the 
routine childhood 
vaccination 
schedule in the 
USA compared 
with no 
immunisation.  
The hypothetical 
study population 
was the 2001 US 
birth cohort.  
Routine 
childhood 
immunisations. 
Effectiveness 
data were 
derived from 
studies 
published 1992 
– 2004, national 
databases and 
expert opinion. 
The resource 
use and cost 
data related to 
1985 – 2004. 
Prices in US 
dollars related 
to 2001. 
Incidence. 
Without vaccination, the 
annual incidence of disease 
per 100,000 population was 
estimated to be: 
600 for diphtheria 
0.3 for tetanus 
4,720 for pertussis 
104 for Hib meningitis 
9.4 for Hib epiglottis 
12 for Hib septicaemia 
13.4 for Hib pneumonia 
14.7 for Hib cellulites 
2.7 for Hib arthritis 
1.3 for Hib other invasive 
disease 
31 for paralytic poliomyelitis 
10,641 for measles 
6,205 for mumps 
3,300 for rubella 
9,839 for varicella. 
With vaccination, the 
annual incidence of disease 
per 100,000 population was 
estimated to be: 
1 for measles, 
7 for mumps, 
0.2 for rubella 
33 for pertussis 
1,091 for varicella 
0 for polio and <0.1 for all 
the other above Hib-related 
conditions. 
⋅ The full vaccination 
schedule would 
prevent 13,622,004 
infection cases and 
save 33,101 deaths. 
⋅ The current 
schedule of 
vaccinations in the 
USA is cost saving. 
For every dollar 
spent, the 
vaccination 
programme saved 
more that $5 in direct 
costs and 
approximately $11 in 
additional costs to 
society. 
⋅ Caution is required 
in interpreting the 
results and 
generalising to other 
settings because of 
the assumptions 
made in the model.  
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Table 3: Results of economic evaluations included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Study 
population 
Intervention Data Results  Authors’ conclusions 
Zhou et 
al, 2004 
USA 
Cost-
effectiveness 
analysis and 
cost-benefit 
analysis.  
To 
evaluate 
the cost-
effective
ness 
and 
economi
c impact 
of the 
two-
dose 
MMR 
vaccinati
on 
program
me in 
the 
USA.  
Hypothetical 
birth cohort 
of 3,803,295, 
infants born 
in 2001 in 
USA, 
followed up 
to the age of 
40. 
Two dose 
MMR 
vaccination or 
one dose 
MMR 
compared 
with no 
vaccination.  
Effective data 
derived from a 
review or 
synthesis of 
literature published 
from 1962 – 
2000.resources 
referred to 1985 – 
2001. Prices in US 
dollars related to 
2001. 
Coverage with 1st dose of MMR 
was 3.98% in children aged <1 
year and 90.2% - 95.0% in 
children aged 1-6 years. 
Coverage with 2nd dose of MMR 
was 0.99% in children aged <1 
year and 79.19% in children 
aged 1-6 years. 
Incidence. 
In a cohort of 3,803,295 children, 
without MMR vaccination there 
were 3,433,722 cases of 
measles, 2,100,718 mumps 
cases, 1,786,334 rubella cases, 
616 cases of CRS and 2,888 
deaths occurred over 40 years. 
without MMR with a 2-dose MMR 
vaccination programme there 
were 686 cases of measles, 
4,801 mumps cases, 2,304 
rubella cases, 14 cases of CRS 
and 3 deaths occurred over 40 
years. 
Compared with the 1-dose MMR, 
the 2-dose programme prevented 
66,712 cases of measles or 
mumps, and 16 deaths. The 2-
dose MMR resulted in an 
additional 1,070 life years saved. 
The net saving from the 2-dose 
programme was $3.513M. The 
cost-benefit ration of the 2-dose 
programme remained greater 
than 1 in all scenarios examined. 
⋅ The 2-dose MMR vaccination 
programme from total direct and 
societal perspective was highly 
cost beneficial and resulted in 
substantial cost savings. The 2nd 
dose eliminated endemic measles, 
which was not achieved with the 
one-dose strategy. The relative 
cost-effectiveness of the 2-dose 
strategy was comparable to that of 
other life-saving interventions in 
the USA. 
Note: The magnitude of the cost-
benefit ration is specific to the size 
of the patient cohort examined and 
cannot be generalised.  
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Table 4: Results of ecological studies included 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Lamden & 
Gemmell, 
2008 
Cumbria and 
Lancashire 
Demographic 
and structural 
analysis.  
To identify 
general practice 
factors 
associated with 
high MMR 
coverage. 
257 general 
practices in 
Cumbria and 
Lancashire in 
2005. 
CHIS (Child Health 
Information Systems) of 
8 PCTs 
Practice structure, 
census indicators for 
deprivation 
Ethnicity data 
At lower level SOA. 
Mean MMR uptake 
86.4% (range 59-98%). 
28% (74/257) achieved 
DH higher target 
payment level of 90%. 
Uptake not associated 
with practice size, 
number of GPs or 
Practice Nurses (PNs). 
No correlation between 
uptake and deprivation 
or white or non-white 
population. 
 
Negative association 
between uptake and 
barriers to housing and 
services (r = -0.2330, 
p<0.001). 
Having a strategic approach is 
important. Practices should ensure 
easy access to child vaccination 
High uptake can be achieved by 
practices in deprived areas. 
Further research is needed to 
identify practice system factors 
associated with high MMR uptake.  
Avis et al, 
2007 
Saskatoon 
Canada 
 
Ecological 
study design. 
To utilise newly 
available data 
from the 
Saskatchewan 
Immunisation 
Management 
System (SIMS) to 
examine city and 
neighbourhood 
uptake of MMR 
vaccine and 
identify potential 
factors that 
contribute to low 
uptake in 
Saskatoon. 
All 10,827 two-
year olds living 
in the city of 
Saskatoon from 
1999 – 2002, 
covered by the 
Saskatchewan 
Health Plan. 
Data from 10,287 SIMS 
records of each child 
who had MMR from 
1/01/96 – 31/12/2002 
used as the numerator. 
Saskatchewan Health 
Covered Population 
Report provided the 
number of 2-year olds. 
Postcode information 
enabled neighbourhood 
assignment. Vehicles 
per capita per 
neighbourhood from 
vehicle data from City 
of Saskatchewan. 
Immunisation rates 
were relatively stable 
between 1999 and 
2002. 
80.6% of variation in 
up-to-date 
immunisation uptake 
could be explained by 
the proportion of single-
parent families headed 
by females and the 
number of vehicles per 
capita registered in the 
neighbourhood. 
There are significant inequalities in 
immunisation uptake at 
neighbourhood level in Saskatoon. 
These findings may indicate the 
presence of real or perceived 
barriers to immunisation in some 
Saskatoon neighbourhoods. 
Inequalities in uptake of MMR may 
be due to lower accessibility of 
health centres, due to lack of a car 
and possible lack of support 
available for single mothers.  
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Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Christakis et 
al, 2000 
Seattle 
USA 
Analysis of 
automated 
data system. 
To assess 
whether 
continuity of care 
is associated with 
timely 
administration of 
MMR vaccine. 
11,233 eligible 
children on the 
Group Health 
Co-operative 
(GHC) of Puget 
Sound, born 1 
January 1993 
to 31 
December 
1997. 
Automated database of 
GHC, 11,233 children 
with comprehensive 
records of immunisation 
and out-patient visits. 
Logistic regression 
used to model the odds 
that the MMR vaccine 
was administered by 15 
months of age.  
Medium continuity on 
the Continuity of Care 
Index (OR 1.20, 95% 
CI, 1.08 to 1.33) and 
high continuity (OR 
1.36, 95% CI, 1.22 to 
1.52) were associated 
with an increased 
likelihood of being 
immunised by 15 
months compared with 
patients with low 
continuity of care.  
Greater continuity of care is 
associated with more timely MMR 
immunisation. 
MMR uptake might be improved in 
the context were health care 
professionals and patients know 
each other better.  
Evans & 
Thomas, 
1998 
Glamorgan 
Wales 
Analysis of 
data from the 
computerised 
child health 
system. 
To identify factors 
associated with 
non-uptake of 
pre-school 
booster 
immunisation. 
All 6184 
children born in 
1990 and living 
in South 
Glamorgan.  
Computerised child 
health system. 
Pre-school booster 
coverage was 91.4%. 
Booster uptake was 
lower among children 
living in urban areas 
and in more deprived 
electoral wards. 
Uptake was strongly 
associated with primary 
immunisation for DTP 
or 1st dose MMR. 
Identifying children who 
miss either primary 
immunisation predicts 
52.4% of those who 
miss the pre-school 
booster. 
Effective targeting of children who 
have missed primary immunisation 
could improve pre-school booster 
uptake and ensure at least one 
dose of MMR.  
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Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Friederichs 
et al, 2006 
Glasgow 
Scotland 
 
Analysis of 
Scottish 
Immunisation 
and Recall 
System 
(SIRS) 
population 
database. 
To determine the 
impact of adverse 
publicity on MMR 
uptake and 
measles 
susceptibility, 
including whether 
vaccination is 
delayed and the 
role of 
deprivation. 
1,079,327 
children born 
1987 – 2004. 
A population database 
for Scotland containing 
immunisation records 
for over 1 million 
children born 1987 – 
2004. Included 
postcode and 
deprivation category. 
6% reduction in 
coverage from 1998 – 
2001. 
The greater the 
deprivation, the greater 
the tendency for late 
vaccination, especially 
for the most deprived 
category. 
Most affluent areas 
tend to be vaccinated 
promptly or not at all. 
An 8-fold rise in number 
of districts with greater 
than 20% susceptibility 
in this group.  
Increasing measles susceptibility in 
nurseries is concerning, particularly 
in the most vulnerable areas. 
These figures are likely to increase 
as MMR uptake has not returned to 
previous levels. Increased 
susceptibility can also be expected 
in primary schools.  
Hawker et 
al, 2007 
Birmingham 
England  
Cohort 
analysis of 
existing 
database of 
child 
immunisation 
records. 
To examine 
whether there are 
differences in 
MMR uptake by 
ethnic group and 
whether MMR 
uptake changed 
by ethnic group 
following adverse 
publicity.  
Cohort of 
children born in 
Birmingham 1 
January 1992 – 
31 December 
1998. 
Computerised child 
immunisation records, 
including ethnic group. 
MMR uptake in 
Birmingham: 
Fell from 91.1% in 1994 
to 89.8% in 2000. 
Highest in Asian 
children 93.1%. 
Lowest in Black 
Caribbean children – 
86.3%. 
Significant differences between 
ethnic groups in Birmingham. 
Ethnic data should be collected 
uniformly. 
Computerised child immunisation 
records need to be up-to-date. 
Further research needed to explore 
the mechanisms underlying the 
differences.  
Henderson 
et al, 2004 
Highlands, 
Scotland 
 
Analysis of 
childhood 
immunisation 
uptake rates.  
To investigate the 
influence of 
practice type and 
call / recall 
systems on 
childhood 
immunisation 
coverage.  
General 
practices in the 
Highland 
Health Board in 
Scotland. 
Immunisation uptake of 
individual practices 
obtained from the 
Information and 
Statistics Division of 
NHS Scotland. 
Uptake of all vaccines 
in children reaching the 
age of 2 years was 
lower in practices using 
their own call / recall 
system than those 
engaged with the 
national system. 
Inducement practices 
Engagement with the national recall 
system was associated with higher 
immunisation coverage for children 
reaching 2 years of age. 
Inducement status was associated 
with low uptake.  
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achieved a lower 
uptake than non-
inducement practices 
for every immunisation 
studied, with 
differences from 4.7% 
to 7.8%. Uptake was 
less in single handed 
practices than group 
practices with 
differences from 2.4% 
to 11.4%. 
Higher uptake of 
diphtheria and MenC 
was associated with the 
use of the national 
recall system. 
Johnson et 
al, 1995 
Dublin 
Ireland 
Cross-
sectional 
sero-survey 
and 
monitoring 
trends in 
measles 
notifications 
and mortality.  
To determine the 
susceptibility of 
3-14 year old 
children to 
measles mumps 
and rubella and 
to relate the 
results to the 
epidemiology of 
measles.  
837 children 
attending 
paediatric out-
patient clinics 
in Dublin in 
1991 and 1992.  
Data from the infectious 
disease notification 
system and vital 
statistics to examine 
trends in morbidity and 
mortality. Blood 
samples taken whilst 
children were already 
having blood taken for 
other investigations. 
Sera tested for 
measles, mumps and 
rubella IgG/IgM 
antibody. 
The prevalence of 
measles antibody was: 
84% for age 3-6, 
83% for age 7-10 and 
95% for 11-14. 
For mumps, antibodies 
were present for: 
48% for age 3-6, 
60% for age 7-10 and 
65% for 11-14. 
For rubella antibody 
prevalence was: 
78% for age 3-6, 
63% for age 7-10 and 
74% for 11-14. 
Outbreaks are inevitable given the 
sub-optimal uptake of MMR. 
A 2-dose MMR vaccination 
programme is essential. 
A primary school MMR ‘top-up’ 
programme would appear to be 
necessary. 
 
 79 
Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Lawrence et 
al, 2003 
Sydney 
Australia  
Cross 
sectional 
design and 
cohort 
analysis of 
existing data. 
Telephone 
interviews 
with a sample 
of 506 
parents with 
no record of 
2nd MMR.  
To assess under-
reporting of MMR 
vaccination to the 
Australian 
Childhood 
Immunisation 
Register (ACIR). 
To estimate MMR 
coverage among 
5-year old 
children and the 
proportion 
immune to 
infection. 
To identify factors 
related to non-
uptake of MMR.  
64,000 aged 
five years born 
1 October to 31 
December 
1995, 
registered with 
ACIR on 4 May 
2001.  
506/1020 (50%) 
parents consented to 
computer-assisted 
telephone interviews 
conducted in July 2001. 
MMR coverage 
calculated for entire 
birth cohort at 5th 
birthday then on 4 May 
2001 to correct for 
under-reporting to the 
ACIR.  
MMR coverage for the 
cohort was 52.9% at 5 
years of age, and 
84.1% at around 5.5 
years of age. 
93% was immune to 
measles due to 
vaccination. 
42% of parents with a 
child with no record of 
2nd MMR had received 
the MMR before their 
child was 5.5 years of 
age. 
The most commonly 
reported reason for 
incomplete vaccination 
was lack of knowledge 
about the age the 
second dose was due 
(29%) and medical 
contra-indications to 
MMR vaccination (18%) 
or that they had 
forgotten the MMR was 
due (16%). 
Disagreement or 
concern was reported 
by 14% parents, most 
commonly because of 
the perception that the 
risks outweighed the 
benefits.  
Continued effort will be required to 
eliminate measles in Australia. 
School entry requirements may be 
a primary driver for 2nd dose of 
MMR. 
Strategies are needed to address 
parental knowledge about the MMR 
vaccination schedule and contra-
indications. 
Strategies are needed to improve 
accurate reporting of coverage. 
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Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Pearce et al, 
2008 
UK 
Nationally 
representative 
prospective 
cohort study. 
Trained 
researchers 
interviewed 
the main 
caregiver, 
usually the 
mother, at 
home. Socio-
economic 
characteristics 
were 
collected. 
To estimate the 
uptake of the 
combined MMR 
vaccine and 
single antigen 
vaccines to 
explore factors 
associated with 
uptake, and 
reasons for not 
using MMR.  
The millennium 
cohort study; a 
longitudinal 
study of 
children born in 
the UK from 
September 
2000 to 
January 2002. 
14,630 
participated 
from 18,296 
invited. 
Immunisation 
data were 
available for 
14,578.  
A random sample of 
electoral wards, 
stratified to ensure 
representation of 
England, Scotland, 
Wales and Northern 
Ireland, deprived areas 
and high proportions of 
families from ethnic 
minorities. Also data 
from the UK data 
archive at the 
University of Essex. 
Forward stepwise 
Poisson regression 
analysis used to 
identify characteristics 
ass with MMR uptake. 
88.6% Immunised with 
MMR 
5.3% received vaccines 
in a single dose. 
5.2% Immunised with 
at least one antigen, 
Children living in a 
household with other 
children or 
with a lone parent, or 
whose mother was 
under 20, 
or over 34 when they 
were born, or 
more highly educated, 
or not employed, or 
self-employed were 
more likely to be 
unimmunised. 
Use of single vaccines 
increased with 
household income, 
maternal age and 
education. 
67% of parents who did 
not immunise made a 
‘conscious decision’ not 
to immunise. 
15% a medical reason, 
6% a practical reason.  
MMR uptake is recovering. A 
substantial proportion of children 
remain susceptible to infection 
because of parents’ decision not to 
immunise. 
Social differentials in uptake could 
be used to inform targeted 
interventions to promote uptake. 
Reminders of immunisation 
appointments and more accessible 
opportunities might be successful. 
Ready access to evidence-based 
information re MMR, tailored to 
particular concerns and beliefs of 
different groups.  
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Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Pearce et al, 
2009 
UK  
Nationally 
representativ
e Millennium 
Cohort Study. 
Stratified 
clustered 
sampling 
design.  
To investigate the 
relationship 
between primary 
immunisation 
status and MMR 
uptake. 
14,578 children 
born in the UK, 
2000 – 2002, 
with 
immunisation 
data. 
Millennium Cohort 
Study (MCS). 
Information collected 
about 9-month old 
infants and 3-year old 
infants. Analysis 
included 14,578 
children aged 3 years 
who had information on 
MMR reported by the 
mother.  
At 9 months, 95.4% 
were reported to be 
fully immunised with 
primary vaccines and 
3.5% partly immunised. 
By 3 years, 96% were 
fully immunised with 
primary vaccines and 
88.6% were immunised 
with MMR. 
5.2% received vaccines 
in a single dose. 
6.1% were 
unimmunised against 
measles mumps and 
rubella at age 3 years. 
Children unimmunised 
with primary vaccines 
at 9 months were 12.6 
times more likely to be 
unimmunised against 
measles mumps and 
rubella compared with 
children who were fully 
immunised. Children 
unimmunised with 
primary vaccines at 3 
years were 16.9 times 
more likely to be 
unimmunised against 
measles mumps and 
rubella compared with 
children who were fully 
immunised. 
Data from a nationally 
representative, contemporary study 
have shown that children who 
remain unimmunised with primary 
vaccines are also more likely not to 
receive MMR. 
Children who do not catch up with 
their missed primary immunisation 
are at greatest risk. 
Tailored information or improved 
access may help. 
More work is needed to determine 
how best to target this group. 
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Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Reading et 
al, 2004 
Norwich 
UK  
A cohort 
analysis of 
cumulative 
immunisation 
uptake of 616 
children aged 
1 – 4 years.  
To investigate 
whether a delay 
in infant 
immunisation is 
associated with 
the number of 
older siblings.  
616 children 
aged 1 – 4 
years selected 
from the lists of 
12 general 
practices in and 
around Norwich 
for a case-
control study of 
atopic 
dermatitis.  
Data on family 
characteristics and 
social circumstances 
were collected at 
interview with the 
child’s mother. 
Immunisation data were 
taken from the 
computerised district 
health records. Data 
were collected from 
1999 to 2001 with a 
further check on 
immunisation status in 
2003.unadjusted odds 
rations were calculated 
for the effect of 
explanatory variables 
on delayed 
immunisation uptake. 
Unconditional multiple 
logistic regression was 
used to identify 
independent effects. 
98% (606/616) children 
completed the primary 
pertussis immunisation 
and 94% (581/616) had 
an MMR. 
Number of older 
siblings was strongly 
associated with a delay 
in pertussis 
immunisation but not in 
MMR immunisation. 
Delay in pertussis was 
significant associated 
with housing tenure and 
mother’s social class 
when the child was an 
infant. 
Delay was associated 
with more 
disadvantage. 
Younger children and 
those with older 
mothers were more 
likely to have delayed 
immunisation.  
Infants with older siblings are at 
greater risk of pertussis infection 
from intrafamilial contagion yet are 
less likely to be immunised on time. 
Practical suggestions include: 
Improving access to clinics 
Reducing inconveniences 
Home immunisation 
Flexible clinic times 
Flexible locations 
Practical help with child care. 
Address concerns in immunisation 
advice in an unbiased and 
reasoned way. 
Samad et al, 
2006a 
UK  
Prospective 
cohort study 
To compare 
demographic, 
social, maternal 
and infant related 
factors 
associated with 
partial 
immunisation in 
the 1st year of life 
in the UK.  
Sample of 
electoral wards 
in England, 
Wales, 
Scotland and 
Northern 
Ireland, 
stratified by 
measures of 
ethnic 
Millennium Cohort 
Study (MCS). 14,578 
children born in the UK, 
2000 – 2002, 
The sample was 
stratified by UK country, 
and electoral wards to 
adequately represent 
infants from ethnic 
minority groups, 
3.3% infants in the UK 
were partially 
immunised and 1.1% 
were unimmunised at 9 
months. Rates were 
highest in England. 
Factors independently 
associated with partial 
immunisation status 
were: 
Mothers of unimmunised infants 
differ in age and education from 
those of partially immunised infants. 
Interventions to reduce incomplete 
immunisation in infancy need 
different approaches.  
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composition 
and social 
disadvantage. 
18,488 infants 
born from 
September 
2000 to 
January 2002, 
resident in the 
UK and eligible 
to receive child 
benefit at age 9 
months.  
disadvantaged 
backgrounds and the 
three Celtic countries. 
The survey response 
rate was 72%. 
Survey interview data 
were gathered when 
the infants were 9 
months old. Data from 
18,488 singletons or 1st 
born infants were 
analysed and estimated 
rate rations using 
Poisson regression.  
Residence in wards 
with disadvantage, 
ethnic wards, larger 
family size, lone 
parenthood, teenage 
parenthood, maternal 
smoking in pregnancy, 
admission to hospital 
by 9 months. 
1.9% of mothers of 
unimmunised infants 
were educated to 
degree level or above, 
3.1% were older (aged 
40 or more), were 
highly qualified, 4.7% of 
mothers of 
unimmunised infants 
were of black 
Caribbean ethnicity.  
Sharland et 
al, 1997 
London 
UK  
An ecological 
study with 
analysis of 
COVER 
(Cover of 
vaccination 
evaluated 
rapidly) data 
and data 
from the 
1991 census.  
To determine 
associations 
between 
indicators of 
social deprivation 
and the uptake of 
primary 
immunisation in 
London to identify 
characteristics of 
families that 
might predict 
non-completion 
of immunisation 
and so facilitate 
targeting of 
resources.  
28 inner and 
outer London 
district health 
authorities in 
1991.  
Immunisation coverage 
data from 28 inner and 
outer London district 
health authorities in 
1991 and small area 
statistics from the 1991 
census. Univariate 
linear regression then 
stepwise linear 
regression.  
Coverage of DTP at 12 
months varied from 
68% to 95% (mean 
86%). 
Coverage of MMR at 24 
months varied from 
61% to 94% (mean 
84%). 
A significant negative 
correlation was found at 
24 months for lone 
parent families and 
MMR coverage. 
A small positive 
association was found 
with unemployment and 
MMR coverage.  
Lone parenthood was identified as 
an important independent risk factor 
in London for non-completion of 
immunisation at 12 months of age. 
Unemployment may facilitate 
uptake as the parent does not have 
to take time off work to attend the 
clinic. 
Targeting families for a domiciliary 
immunisation service may improve 
coverage. 
An economic evaluation is needed 
to determine whether such a 
service would be cost-effective. 
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Table 4: Results of ecological studies included (continued) 
Authors, 
Year, 
Country  
Design / 
Method 
Aim Population  Data Results  Authors’ conclusions 
Skinner at 
al, 1998 
Melbourne 
Australia 
Prevalence 
surveys of 
uptake rates 
of age 10 – 
11 years 
MMR uptake 
and age 13 – 
14 hepatitis B 
vaccination.  
To measure the 
uptake of MMR 
among 10 – 11 
year olds and 
hepatitis B 
vaccination 
among 13 – 14 
year olds.  
Survey of 
1160 school 
children aged 
10 – 11 and 
1102 school 
children aged 
13 – 14. 
1160 school children aged 10 
– 11 and 1102 school 
children aged 13 – 14. 
Coverage of MMR was 83%. 
Uptake of HepB was 77%. 
There was a higher uptake of 
MMR in non-government 
primary schools.  
Relatively little is known about the 
adolescent immunisation target 
population. Further research is 
required to assess factors 
influencing uptake of vaccination in 
the adolescent age group (school 
vaccination policy, teacher 
commitment, teacher-delivered 
material, school nurse role). 
Further consideration need to be 
given to the delivery in schools, 
clinics or by GPs. 
Thomas et 
al, 1998 
Wales 
Prevalence 
survey of 
MMR uptake.  
To assess 
progress in the 
‘catch-up’ 
programme in 
immunisation 
coverage for 
each birth 
cohort and 
each of the five 
Welsh HA. 
126,550 
children born 
in Wales 
from January 
1990 to 
march 1993. 
The child health computer 
system  
63,855 (50.5%, range: 35.4 – 
58.3%) had received two 
doses of MMR. 120,668 
(95.4%) had received one 
dose. 
5,882 (4.6%) had no record of 
receiving any MMR. 18.4% 
unimmunised attended for the 
MMR catch-up.  
The ‘catch-up’ programme may not 
reach the children who most need 
to be immunised. 
Successful elimination may depend 
on targeting this group.  
Wright et 
al, 2005 
England  
Ecological 
study of 
immunisation 
coverage by 
second 
birthday  
To assess the 
geographical 
variation in 
trends in MMR 
coverage and 
identify factors 
affecting MMR 
coverage at 
population 
level. 
Children 
whose 
birthday was 
1st April 1999 
and 31st 
March 2000 
in 95 DHAs. 
Routinely collected of 
COVER (Cover of 
vaccination evaluated 
rapidly) data from 1993 – 
2004 for England and a 
summary KC50 form 
completed by individual 
health authorities. Trends 
were assessed for 95 District 
Health Authorities. Also 
Experian Mosaic data which 
uses housing and vehicles 
when measuring social class.  
Since 2000 MMR coverage 
declined in most areas of 
England. Population density 
and deprivation strongly 
correlated with MMR uptake. 
Decline in coverage related to 
proportion of educated 
population. Greater in densely 
populated areas. 
% coverage for DTP and polio 
significantly related to MMR 
coverage (r=0.76, p=0.00). 
1st study to examine socio-
economic factors influencing MMR 
uptake. In all DHAs peak MMR 
coverage was in 2000 or earlier. 
Decline in coverage affected most 
areas of England. The lowest rates 
of MMR coverage remain in urban 
areas, particularly inner cities, 
which also tend to show high levels 
of deprivation. Public health 
resources should target inner city 
areas, and focus on concerns of the 
better educated about safety.  
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Table 5: Results of studies of health care professionals (surveys & questionnaires) 
Authors, 
year 
Aim of study Design 
methods 
Sample  Response 
Rate 
Results/Findings  Comments/Study Limitations 
Henderson 
et al (2004) 
Scotland 
Assessment 
of GPs’ views 
on 
vaccination 
issues. 
Semi-
structured 
postal 
questionnaire 
(2 mailings). 
GPs working 
in the 
Highland 
Region of 
Scotland 
(n=282). 
73%. 28% expressed concerns about 
side-effects of MMR compared with 
other vaccines (p<0.000); 
98% thought benefits of vaccination 
outweighed possible risks, however, 
only 91.7% and 85.7% believed this 
to be true for 1st and 2nd dose of 
MMR respectively (p=0.007); 
Only 57% were ‘very confident’ in 
discussing MMR vaccine with 
parents, compared to 75% for DTP-
Hib vaccine (p<0.001); 
A number of GPs held erroneous 
beliefs regarding the adverse 
events associated with MMR, with 1 
in 5 being unaware of the true side-
effects; 
GPs felt that parents distrusted 
government information regarding 
MMR; 
44.6% expressed a wish for further 
training on immunisation issues. 
Questionnaires had been used in previous 
studies; 
Pilot study was undertaken; 
Analysis of non-respondents was undertaken 
(no differences); 
HVs were found to have a more prominent role 
in vaccination compared with GPs, and 
therefore data may not be an accurate 
reflection of issues. 
 
Study recommendations 
⋅ Further education initiatives should include all 
healthcare professionals involved in 
immunisation; 
⋅ Educational sessions may be combined with 
other measures shown to be effective, 
including reminders to doctors about children 
requiring vaccination, and assessment and 
feedback to practices on the vaccination 
coverage of children registered with them; 
⋅ A ‘diagnostic analysis’ should be undertaken 
to identify obstacles to change, and that any 
intervention planned should be targeted at 
overcoming them. 
Lamden & 
Gemmell, 
2008 
Cumbria 
and 
Lancashire 
England 
To identify 
general 
practice 
factors 
associated 
with high 
MMR 
coverage. 
Confidential 
questionnaire 
survey sent to 
each practice, 
for one 
collective 
response. 
PNs in 257 
general 
practices in 
Cumbria and 
Lancashire. 
195/257 
(75.9%) 
responded. 
No association between MMR 
uptake and number of PNs. 
MMR given by a GP in 42.8% 
practices, a PN in 54.8% and a HV 
in 60.5% practices. 
The proportion of HVs vaccinating 
in each PCT ranged from 28% - 
100%. 
PNs said: 
91.8% had a ‘teamworking’ 
approach to MMR, 
79.4% had a self-reported strategic 
There was no association between 
immunisation by GP, PN or HV. 
Having a strategic approach with clear 
objectives was the only factor significantly 
associated with achieving an MMR uptake of 
over 90%. 
Further research is needed to identify practice 
system factors associated with high MMR 
uptake.  
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approach with clear objectives, 
42.3% discussed MMR in detail at a 
practice meeting. 
82% had a system for contacting 
non-attenders, 
15% used the MMR video, 
11% had audited reasons of non-
attendance. 
24.7% knew their MMR uptake. 
Petrovic et 
al (2001) 
North 
Wales, UK 
To determine 
the 
knowledge, 
attitudes and 
practices 
among health 
professionals 
regarding 
MMR, 
particularly 
the 2nd dose. 
Postal survey 
questionnaire. 
GPs (n=206), 
HVs (n=148), 
PNs (n=239). 
80% GPs 
(n=165), 
95% HVs 
(n=140), 
85% PNs 
(n=204) 
48% of the sample had reservations 
about 2nd dose, and 3% disagreed 
with giving it. HVs were nominated 
as the best source of advice. 61% 
of HVs compared with 46% of GPs 
reported feeling very confident 
about explaining the rationale of a 
two dose schedule to a well-
informed parent, but only 20% 
would recommend the 2nd dose to a 
wavering parent. 33% of PNs 
thought there was a link between 
the vaccine and Crohn’s disease, 
and 27% that it was associated with 
autism. Nearly one fifth of GPs 
reported they had not read the 
relevant guidance on MMR. 
Self-selection and non-response bias? 
 
In response to this study, North Wales Health 
Authority’s department of public health is 
constructing a MMR vaccination resource pack 
that contains evidence-based information and 
is designed for use by health professionals 
during consultation with parents. 
Smith et al 
(2001) 
Greater 
Manchester, 
UK 
Exploration of 
health 
professionals’ 
confidence in 
MMR vaccine  
Assessment 
of health 
professionals’ 
knowledge 
and attitudes 
towards 
MMR 2nd 
dose. 
Questionnaire 
Survey (2 
rounds) sent 
to all GPs, 
PNs and HVs 
in Salford and 
Trafford 
Health 
Authority 
area. 
GPs (n=236), 
PNs (n=78) 
and 
HVs (n=40) of 
Salford and 
Trafford 
Health 
Authority. 
Overall = 
62% 
(GPs=57%) 
(PNs=64%) 
(HVs=75%). 
Confidence in vaccine fell from 
59.4% to 40.9%; 40% of 
respondents were unsure about the 
need for a 2nd dose; 1 in 10 
respondents stated that 2nd dose 
was not necessary; PNs and HVs 
were less confident than GPs; 61% 
of sample felt that more research 
was warranted; GPs were more 
aware of the need for a 2nd dose; 
Health professionals were more 
likely to encourage uptake of the 1st 
dose compared with 2nd. 
20% of response data were “randomly 
validated” using a computerised questionnaire 
application (SNAP); 
No exploration of non-respondents; 
No statistical analysis of results, yet authors 
report a ‘significant fall in confidence’; 
No information about questionnaire validation. 
 
Study recommendations 
⋅ HVs and nurses in particular should be 
targeted. 
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Table 6: Results of studies of parental surveys & questionnaires 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response 
rate 
Results/Findings  Comments/Study 
Limitations 
Alfredsson et 
al, (2004) 
Sweden 
To study 
reasons why 
parents 
choose not to 
vaccinate 
against MMR. 
Postal 
questionnaire. 
Parents of 
two 
identified 
birth cohorts 
with children 
born in 1995 
& 1996 
(n=250) 
42% 
(28% in 
areas with 
high non-
vaccination 
rates; 
32% from 
vaccinated 
children). 
Children without MMR vaccination were 
also more likely to be unvaccinated 
against other diseases (p=0.003); 
The main reasons for choosing not to 
vaccinate were that vaccines were 
thought harmful, and that the diseases 
were harmless or even beneficial; 
A greater proportion of parents with 
unvaccinated children reported they 
had some knowledge of the MMR 
vaccination before the visit, but they 
had less accurate information about the 
vaccine; 
20% of the parents with unvaccinated 
children had not decided upon 
vaccination before the clinic visit – 
these parent were the least satisfied 
with the way they were received at 
clinic and the information given; 
40% of unvaccinated group and 30% of 
vaccinated group stated that not 
enough time was allocated for 
questions and discussions (p<0.05). 
Low response rate; 
Data biased in relation to 
children who are already 
vaccinated. 
 
Study recommendations 
⋅ Physicians have to take 
more time to listen and 
discuss in order to 
strengthen the doctor-
patient relationship; 
⋅ It needs to be taken into 
account that parental 
knowledge may not be 
based on scientific data. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response rate Results/Findings  Comments/Study 
Limitations 
Cassell et al 
(2006) 
Brighton, 
UK 
To explore 
social and 
cultural 
influences, 
and health 
beliefs 
associated 
with low 
uptake of 
MMR. 
Postal 
questionnaire. 
Parents of children 
aged 15-24 months 
whose children had 
and had not been 
vaccinated (n=1,135). 
39.8% (n=452). Mothers were more likely to 
accept MMR for a first child 
than for subsequent 
children (p=0.002); 
17.5% had chosen single 
jabs; 
10.6% had chosen to delay 
a decision about 
vaccination; 
Of the non-compliant 
mothers, 32.6% had 
consulted a homeopath, 
compared with 10.1% of 
compliers (p=0.001); 
Rejection of the vitamin K 
injection routinely offered at 
birth was strongly 
associated with non-
compliance (p<0.001); 
58% of non-compliers 
reported concerns about 
MMR before the birth of 
their child, being more 
concerned about family 
health issues related to 
MMR, and less likely to see 
measles as a serious 
disease; 
Non-compliers were 
significantly more likely to 
have attended public 
meetings on immunization 
(p<0.001), had read books 
on MMR (p<0.001), and 
seen documentaries 
Low response rate; 
Not representative of normal 
population 
 
Study recommendations 
⋅ The findings demonstrate 
the need for immunisation 
information that 
acknowledges and 
addresses lay concepts of 
immunity. 
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(p=0.048); 
Mistrust of the government 
and pharmaceutical 
companies was strongly 
expressed; 
A significantly higher 
proportion of non-compliers 
claimed to have stopped 
eating beef because of 
BSE, with 35% being 
vegetarian already; and 
also checked food labels to 
see if they contain GMOs. 
Flynn & 
Ogden 
(2004) 
Brighton, 
UK 
To describe 
parents’ 
beliefs about 
MMR and to 
explore the 
best 
predictors of 
uptake by the 
age of 2 
years. 
Prospective 
questionnaire 
and analysis 
of subsequent 
uptake data 
from child 
health 
records. 
Parents of children 
who were due to 
receive an invitation 
for MMR 
immunisation 
(n=898). 
56.9% (n=513). Over half the respondents 
showed only moderate 
agreement that they had 
been encouraged by others 
to have their children 
vaccinated, with only a 
small minority reporting 
they had clearly been 
discouraged; 
Almost half of respondents 
disagreed that vaccines 
were unhealthy, but almost 
as many were unsure; 
The majority reported 
having little faith in the 
media, and had mixed 
confidence in doctors; 
Uptake of MMR was related 
to: previous attendance for 
vaccination, 
increased faith in the 
medical profession, 
increased faith in the 
media, and a lower belief 
that vaccination is 
unhealthy. 
Questionnaire was developed 
from previous qualitative 
studies and piloted; 
No analysis of non-
respondents 
 
Study recommendations 
⋅ If doctors wish to 
encourage parents to 
vaccinate their children, 
they need to promote 
positive views about both 
themselves and the MMR 
vaccination itself. 
⋅ Doctors could place more 
emphasis on encouraging 
uptake for earlier, less 
controversial vaccinations 
and use these vaccinations 
as an opportunity for 
discussing issues about 
MMR. Such an early 
emphasis may create a 
culture of vaccination 
uptake which could itself 
become self-perpetuating. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response 
rate 
Results/Findings  Comments/Study Limitations 
Gellatly et al 
(2005) 
Edinburgh, 
UK 
To identify 
factors 
relevant to 
MMR 
immunising 
and non-
immunising 
parents and 
the extent to 
which these 
factors 
predicted 
decisions. 
Two-stage 
mixed-method 
design. Delphi 
technique 
elicited 
parents views 
of factors 
which were 
then 
incorporated 
into a 
questionnaire. 
Logistic 
regression 
was used to 
predict 
outcome. 
Cluster sample of 
all parents whose 
children attended 
day-care nursery 
(n=182). 
60.4% 
(n=110). Of 
these, 72.7% 
had had their 
child 
vaccinated 
and 27.3% 
had refused 
the vaccine. 
4 factors significantly predicted 
vaccination status: the influence 
of current research (OR=0.18, 
95% CI=0.07-0.51), the 
helpfulness of leaflets and 
information packs (OR=3.27, 
95% CI=1.38-7.75), the 
importance of eradication of 
rubella (OR=2.42, 95% 
CI=1.01-5.78), and the 
importance attached to the risk 
of adverse reactions (OR=0.65, 
95% CI=0.48-0.87). 
These factors have not previously 
been identified as salient, although 
only 2 out of 4 have high ORs. An 
alternative way of interpreting these 
should have been that those who did 
not vaccinate their children placed 
more importance on these factors 
(current research and risk of adverse 
reaction). 
Study recommendations 
⋅ Parents of both groups perceive the 
health advice they receive on this 
issue to be entirely distinct from 
relevant research findings. More 
needs to be done to demonstrate 
that current advice is informed by 
and reflects the state of 
accumulated research knowledge. 
Gellin et al 
(2000) 
USA 
To assess 
parents’ 
understanding 
of vaccine-
preventable 
diseases, 
vaccines, 
immunization 
practices and 
policies. 
Telephone 
survey. 
Nationally 
representative 
group of parents 
with children 
aged 0-6 years, 
and expectant 
parents 
(n=16,248 
telephone calls). 
1600 
interviews 
were 
conducted. 
87% of respondents deemed 
immunization extremely 
important, but a significant 
minority held misconceptions 
such as believing the child’s 
immune system could become 
weakened and that children get 
more vaccinations than is good 
for them. Children’s healthcare 
providers were cited as the 
most important source of 
information. 
Interviews were only conducted in 
English, low response rate. 
No analysis of non-respondents. 
 
Study recommendations 
⋅ Communication efforts should focus 
on clarifying and reaffirming 
parents’ correct beliefs about 
immunization and on modifying 
misconceptions. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response rate Results/Findings  Comments/Study 
Limitations 
Gust et al 
(2003) 
USA 
To explore 
parental 
perceptions 
surrounding 
risks and 
benefits of 
immunisation. 
Data from 
national 
survey 
4,800 adults. 72%. 57% of parents found 
numbers and statistics most 
helpful when asked about 
understanding the benefits 
and risks of vaccines. A 
substantial minority (17%) 
of parents were somewhat 
or not confident in vaccine 
safety. Parents with less 
confidence agreed less with 
following their doctor’s 
advice. Parents in the 
lowest income category had 
a significantly lower level of 
agreement in the protective 
value of vaccines, had a 
higher level of agreement 
that their child may have a 
serious side-effect, and a 
lower level of agreement 
that their child may get the 
disease and cause others 
to get the disease if 
unvaccinated. High school 
graduates had a 
significantly lower level of 
agreement in the protective 
value of vaccines and 
whether their child may get 
a disease if unvaccinated. 
Study recommendations 
⋅ The positive relationship 
between confidence in 
vaccine safety and reliance 
on doctors for advice may 
indicate the need for 
healthcare providers to 
identify opportunities to (1) 
solicit questions about 
vaccine safety, (2) address 
vaccine safety-related 
questions in a way 
meaningful to parents, and 
(3) strengthen doctor-
patient relationships. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response rate Results/Findings  Comments/Study Limitations 
Murphy et al, 
1994 
Dublin, 
Ireland 
To establish 
the need for 
opportunistic 
MMR 
immunisation 
among 
paediatric 
A&E 
attenders in 
three Dublin 
paediatric 
hospitals and 
examine the 
relationship 
between 
immunisation 
status and 
socio-
economic 
factors. 
Two-month 
cross-
sectional 
study in May 
and June 
1991. Survey 
interview data 
were 
compared with 
information on 
the Eastern 
Health Board 
record system.  
337 parents of 
eligible children 
were born 
between 1st May 
1986 and 31st 
December 1989; 
aged 15 months 
to five years.  
98.2% 
(337/343). 
There was a history of 
MMR vaccination in 66% 
(223/337) children. 
Reasons given for non-
vaccination were 30% for 
medical reasons, such as 
frequent colds and a family 
history of epilepsy, and 
30% were overlooked. 
Study recommendations 
⋅ Increase parental knowledge of 
the implications of measles and 
rubella. 
⋅ Educate health care professionals 
about appropriate contra-
indications. 
⋅ Data quality standards to be 
improved. 
⋅ A&E departments to be equipped 
to ascertain immunisation status. 
⋅ Opportunistic immunisation 
initiated in paediatric A&E 
departments. 
⋅ Immunisation should be 
performed in A&E departments by 
a nominated nurse with protected 
time to carry out this role. 
Pareek & 
Pattison, 
2000 
Birmingham, 
UK 
An 
investigation 
of factors that 
influence the 
intentions of 
mothers to 
vaccinate with 
MMR. 
Survey. 300 mothers of 
children aged 
between 5 and 12 
months (prior to 
first MMR 
vaccine) and 
between 21 and 
35 months (prior 
to second MMR 
vaccine). 
59%. Fewer mothers intended to 
take their children for the 
2nd MMR vaccination than 
the 1st (p<0.001). 
These mothers expressed 
more negative beliefs about 
the vaccine outcome 
(p<0.001), were more likely 
to believe it was unsafe 
(p=0.004) and that it rarely 
protected (p=0.014). 
29.8% cited autism as a 
side effect; 
The most trusted source of 
information was the GP, but 
Non-response analysis undertaken 
– no differences in vaccination 
rates, but there was an over-
representation of white British 
respondents, and an under-
representation of ethnic minorities 
(comparable with other surveys of 
this nature). 
 
The GP’s role in education would 
appear to be central but many are 
afraid that broaching the subject 
with parents would put them off 
vaccination altogether. 
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the most common source of 
information on side-effects 
was the TV. 
For those approaching the 
1st MMR vaccination, only 
‘vaccine outcome beliefs’ 
significantly predicted 
uptake; 
For those approaching the 
2nd dose, ‘vaccine outcome 
beliefs’, ‘attitude to the 
MMR vaccine’, and ‘prior 
MMR status’ all predicted 
intention. 
Study recommendations 
⋅ Educational campaigns at the 
national and local level need to 
emphasise the safety of the MMR 
vaccine and the danger of 
vaccine-preventable diseases, 
but which also emphasise the 
efficacy of the vaccine and 
delineate the rationale behind the 
two-dose schedule. 
Petrovic et 
al, 2003 
North Wales, 
UK 
To identify 
factors 
associated 
with non-
uptake of the 
2nd dose of 
MMR. 
Case control 
study 
comparing 
responses 
from 
questionnaires 
(2 repeat 
mailings). 
Parents of 
children who had 
accepted all 
vaccines 
including MMR 
(n=200) 
compared with 
parents of 
children who had 
received all 
vaccines except 
the 2nd dose of 
MMR (n=101). 
74.3% for non-
acceptors 
(n=75) and 
77.5% for 
acceptors 
(n=155). 
Non-acceptors were more 
likely to report having 
received information from 
newspapers/TV or from the 
GP; and more likely to 
report having a lot or some 
influence from these 
mediums. (95% CI). 
Non-acceptors were 
significantly more likely to 
have a worry about the 
MMR vaccine. 
The most common reason 
for not accepting the 2nd 
dose was that the child had 
had one dose already and 
this was deemed enough, 
and that parents were 
worried about the side-
effects. 
Recall bias could be a problem 
 
Study recommendations 
⋅ Parental concerns require an 
open, empathetic dialogue in 
which health professionals need 
to effectively communicate the 
best and most up-to-date 
scientific evidence, while bearing 
in mind the internal validity of 
parental concerns and the multi-
faceted nature of risk perception 
and risk communication. 
⋅ School entry and times when 
other vaccinations are given 
would be good opportunities for 
catch up in a school setting. 
⋅ Parents’ objections appear 
transient, and catch-up 
campaigns are therefore likely to 
have a significant impact on 
coverage. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response rate Results/Findings  Comments/Study Limitations 
Samad et al, 
2006b 
UK 
 
Prospective 
longitudinal 
cohort study. 
Mothers 
interviewed at 
home when 
the baby was 
9 months old. 
To examine 
the reasons 
given by 
mothers for 
either 
incompletely 
or not 
immunising 
their infants 
with the 
primary 
vaccines, 
(DTP, polio, 
Hib and 
MenC). 
Millennium 
Cohort Study 
(MCS). 18,819 
infants born in the 
UK, September 
2000 – January 
2002. 
Sample of 
electoral wards in 
England, Wales, 
Scotland and 
Northern Ireland, 
stratified by 
measures of 
ethnic 
composition and 
social 
disadvantage to 
adequately 
represent infants 
from ethnic 
minority groups, 
disadvantaged 
backgrounds and 
the three Celtic 
countries. 
18,488 infants 
born from 
September 2000 
to January 2002, 
resident in the UK 
and eligible to 
receive child 
benefit at age 9 
months.  
The survey 
response rate 
was 72%. 
Survey 
interview data 
were gathered 
when the 
infants were 9 
months old. 
95.6% infants 
(17,544/18,488) were 
reported to be fully 
immunised, 3.3% 
(712/18,488) partially, and 
1.1% (232/18,488) 
unimmunised. 
For infants partially 
immunised, 45% (328/697) 
mothers cited medical 
reasons, 32% (235/697) 
cited problems with health 
services / accessibility, and 
12% (57/697) cited beliefs 
or attitudes towards 
immunisation. 
For non-immunised infants, 
33% (84/228) mothers cited 
medical reasons, 
12% (29/228) cited 
problems with health 
services / accessibility, and 
47% (92/228) cited beliefs 
or attitudes towards 
immunisation. 
The first large scale study to 
explore the incompleteness of 
immunisation uptake. 
An understanding of maternal 
reasons for incomplete 
immunisation may assist in 
identifying appropriate interventions 
to maximise uptake. 
Accessible health care services 
should be provided. 
Children who do not attend should 
be followed-up appropriately. 
Health care professionals require 
training to ensure parents are 
provided with accurate and 
consistent information and ally 
parental concerns. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response rate Results/Findings  Comments/Study Limitations 
Simpson et 
al, 1995 
Bath 
UK 
To explore 
reasons for 
non-uptake of 
childhood 
immunisation.  
Postal 
questionnaire. 
Parents who had 
not taken up 
immunisation for 
their children 
(n=106). 
82% (87/106) 
replied. 
21% (22/106) parents gave 
homeopathy as the reason 
they did not have their child 
immunised. 16% (17/106) 
said religious beliefs were 
the reason and 5% (5/106) 
said the reason was 
‘medical’. 
“The study has allowed the 
identification of groups that might 
benefit from more informed and 
accurate information.” 
Families should have the opportunity 
to discuss concerns with the district 
immunisation co-ordinator. 
Smailbegovic 
et al (2003) 
London, 
UK 
Exploration of 
knowledge, 
attitudes and 
concerns of 
parents who 
have not 
completed 
immunisation 
course. 
Questionnaire 
(2 rounds) and 
interview. 
Parents of 
children resident 
in the London 
Borough of 
Hackney 
identified from the 
child health 
database as 
having defaulted 
for one or more 
primary 
immunizations 
(n=129). 
69% 
(10 
respondents 
were 
interviewed). 
MMR vaccines were most 
frequently omitted (57%); 
33.8% thought 
immunization with above 
vaccine was more risky 
than non-immunization; 
Those interviewed were 
notably concerned about 
MMR vaccine, but not 
immunization in general; 
Parents in interview group 
perceived information 
provided by health 
professionals to be ‘poor’, 
and ‘biased’ although this 
was not found in 
questionnaire sample; 
All mothers in interview 
sample had ‘major’ 
concerns relating to MMR 
vaccine; 
Ethnicity and religious 
beliefs affected perceptions 
of risk. 
Questionnaire was piloted (n=7); 
No statistical analysis; 
Immunisation information reported for 
non-respondents to address non-
response bias; 
Generalisability of findings is limited 
due to small numbers; 
Interview sample were self-selecting 
(half the families had contact with 
parents of children with autism and 
suspected a link). 
 
Study recommendations 
⋅ Parents require information that is 
up-to-date, tailored to their 
individual needs and provided by 
health professionals who are well 
informed; 
⋅ Interventions aimed at improving 
overall uptake may serve to widen 
the gap in uptake across social 
classes. 
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Table 6: Results of studies of parental surveys & questionnaires (continued) 
Authors, 
Year, 
Location 
Aim of study Design 
/Method 
Sample Response rate Results/Findings  Comments/Study Limitations 
Wroe et al 
(2005) 
Bromley, 
London, 
UK 
To investigate 
parental 
decisions 
about MMR 
and single 
vaccinations. 
Questionnaire. Parents recruited 
via Bromley PCT 
(n=216). 
52.7%  
n=114. 
Parental decisions were 
explained by emotion-
related variables, 
specifically anticipated 
responsibility and regret; 
Parents decisions were 
strongly influenced by the 
idea that harm that occurs 
as a result of deciding to 
immunise is less 
acceptable than harm that 
occurs as a result of 
deciding not to immunise; 
Media reports that were 
emotional and 
sensationalised were likely 
to have a direct effect on 
emotions, possibly 
increasing the sense of 
responsibility and 
anticipated regret of an 
action that may cause 
harm. 
Low response rate, possible bias 
Sample was more educated than 
normal population sample; 
Conclusions based on theoretical 
assumptions. 
 
Study recommendations 
⋅ It is important that decision-makers 
are provided with the best available 
evidence, and are given help to use 
this information in a way that fits 
with their values, as opposed to 
basing decisions on emotional 
information. 
 
⋅ Science stories could be turned into 
‘narratives’ that are interesting, 
accessible and informative. 
Yarwood et 
al, 2005 
(and Ramsay 
et al, 2002) 
 
To obtain 
information on 
mothers’ 
knowledge of 
immunisation; 
attitudes 
towards 
immunisation; 
experiences 
of 
immunisation; 
and to 
20 surveys 
from October 
1991 to March 
2001. 
Random 
location 
sampling. 
15,000 interviews 
with parents as 
part of the 
Immunisation 
Policy, Monitoring 
and Surveillance.  
150 
consecutive 
households in 
132 randomly 
selected 
enumeration 
districts until 
quota obtained. 
Spontaneous awareness of 
MMR and MenC has 
increased. 
Mothers are most likely to 
rate the consequences of 
getting meningitis C and 
polio as ‘very serious’ 
compared with the other 
illnesses. 
A rapid decline in perceived 
safety of MMR was 
apparent from 2000 – 2001. 
Comments/Study Limitations 
⋅ The parents are most likely to 
discuss immunisation with the HV in 
particular. 
⋅ Mothers are more influenced by the 
perceived risks a vaccine carries, 
rather than balancing the overall 
risks and benefits from vaccinating 
or not vaccinating. 
⋅ Whilst there had been an increase 
in mothers concerns about the 
safety of MMR, 92% of mothers still 
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monitor the 
recall an 
interpretation 
of NHS II 
advertising 
and 
immunisation 
information 
materials.  
MMR is most likely to be 
considered to present a 
greater risk than the 
disease it protected 
against. 
About 55% of respondents 
had discussed 
immunisation with a HV, 
20% with a GP and 10% 
with a midwife or clinic 
nurse. Almost 30% 
discussed it with a husband 
or partner. 
The two most frequently 
mentioned sources of 
publicity were television 
advertisements and 
leaflets. 
Recognition of an 
immunisation leaflet 
declined to 50% in 2001. 
“Parents’ fears over vaccine 
safety are reflected by 
uptake data”. 
May be because mothers 
no longer aware of the risk 
of disease or have difficulty 
assessing risk.  
intended to fully immunise any 
future child. 
⋅ Materials must be accessible to the 
wider community to explain the 
importance of immunisation, not just 
those directly involved. 
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Table 7: Qualitative studies included 
Authors, 
Year, Place, 
Country  
Design / 
Method 
Aim Description of 
Participants 
Sample size Results  Recommendations 
Brownlie & 
Howson, 
2005a, & 
2006. 
Scotland. 
Secondary 
qualitative 
analysis of 
transcripts 
from data 
sets from 
commissione
d projects (1 
and 2). 
To explore 
the 
interpretative 
elements of 
trust evident 
in parental 
and 
professional 
talk of MMR 
vaccination.  
Study 1: Original data 
set included eight 
focus groups with 
parents (stratified by 
deprivation category) 
and three focus 
groups with HVs and 
Practice Nurses and 
15 telephone 
interviews with GPs. 
Study 2: Eight focus 
with parents from 
three health boards, 
three focus groups 
with HVs and 5 
telephone interviews 
with GPs. 
Not given. Trust or mistrust emerges as an issue 
when the individual making the decision 
struggles with judging probabilities. 
 
Uncertainties may have a basis in 
knowledge gaps e.g. why cannot single 
vaccines be given? 
 
Knowledge gaps merely reinforce the 
difficulties of being informed. Good 
parents ‘know’. 
 
Suspension of trust does not happen in 
isolation and occurs within relationships 
and networks. Trust peers more than 
HCPs. 
 
Building trust is an important part of 
trusting HCPs. GPs have minimal contact 
with parents and therefore few trust 
building opportunities. HVs greater contact 
but trust building threatened by targets. 
 
HCPs make non compliant parents feel 
like ‘bad parents’. 
 
Risk anxiety made worse by mistrust in 
government health messages. 
 
MMR represents a ‘leap of faith’ by 
parents and building trust may make it 
easier for parents to accept information as 
reliable. 
Avoid problematising 
MMR uptake as 
parental non 
compliance as a 
consequence of faulty 
information 
processing. 
 
Move from information 
giving to (re)building 
trust so any 
information is 
perceived as 
trustworthy. 
 
Personal disclosures 
(by GPs & HVs) about 
MMR decision making 
seen as important in 
contributing 
trustworthy 
information.  
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Table 7: Qualitative studies included (continued) 
Authors, Year, 
Place, Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
Casiday, 2007 
Durham & 
Cambridge. 
England  
Focus Groups 
(n=16)and 
individual 
(n=71) 
interviews. 
To explore 
parental decision-
making about 
MMR 
vaccination. 
Volunteer and snowball 
sample. 77 mothers, 10 
fathers 
56 MMR immunisers, 16 
SV immunisers, 10 non 
immunisers, and 5 
undecided. 
MMR uptake rates 83% 
and 88%. 
n=87. Process of weighing risks: 
Statistical probabilities, which 
risks were unacceptable, risks of 
exposure, social context, 
previous experience and 
emotions. 
Overloading the immune system 
a concern 
Specific children as more 
vulnerable/susceptible 
particularly if they already have 
asthma/eczema. 
 
Fear of being considered a bad 
parent increased compliance 
Dissonance between 
responsibilities to public health 
(herd immunity) and protecting 
own child – if perceived MMR 
risk low and MMR vaccine risk 
high then no desire to immunise 
to protect others 
Government perceived as 
mishandling/dishonest in MMR 
debate. 
 
GPs who demonstrated concern 
for their child trusted but those 
that sought to protect the 
population or their professional 
reputation were not trusted. 
GPs need to engage 
in discussions with 
parents and listen to 
fears/risk concerns. 
 
The right narrative 
needs to be presented 
by a believable voice.  
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Table 7: Qualitative studies included (continued) 
Authors, Year, 
Place, Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
Evans et al, 
2001 
Avon & 
Gloucestershire
. 
England  
Focus Group 
Modified 
Grounded 
Theory. 
To investigate 
parents’ 
decisions to 
accept or refuse 
MMR. 
Purposive sample. 
Parents of children 14 
months - 3 years 
43 Female, 5 Men 
Age 22- 48 years 
Immunisers and non-
immunisers in separate 
Focus groups (numbers 
not given) 
54% graduate. 
 
n=48. 
 
All unhappy about MMR and few 
approached MMR with 
confidence 
Non-immunisers felt risk of 
serious complications from 
measles low. 
Previous experience of serious 
illness did not influence MMR 
uptake. 
Some children perceived as 
more vulnerable and therefore at 
greater risk from side effects of 
immunisation. 
Important to increase natural 
immunity. 
Combined vaccine created 
undue immunological stress. 
Factors that contributed to 
decision making were: 
Media. 
DH Guidance/Government 
treated with distrust 
GPs were not perceived as 
independent (immunisation for 
reward). 
HCPs did not give balanced 
information. 
Pressure to comply increased 
resistance. 
Exercise of choice. 
Single vaccine preferred. 
Immunisation decision was not 
rational risk/benefit analysis 
Preferred behaviour act of 
omission rather than 
commission. 
HCPs need help to 
develop more open 
approach and skills in 
shared decision 
making with patients. 
Range of information 
available prior to 
decision including 
MMR schedule 
Risk for boys & girls 
Duration of protection. 
Rationale for boosters 
Immunity and breast 
milk. 
Optimum age for 
protection. 
Suggested that MMR1 
be given pre-school. 
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Table 7: Qualitative studies included (continued) 
Authors, Year, 
Place, Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
Henderson et 
al, 2008 
North East 
London. 
England  
Qualitative 
interviews. 
To assess 
reasons for low 
uptake of 
immunisation 
amongst 
orthodox Jewish 
families. 
Volunteer and snowball 
sample orthodox Jewish. 
Mothers (n= 25) and 
health care workers 
(n=10). 
n=35. Community perceived 
themselves to be relatively 
insulated from media but talk 
nevertheless persuasive. 
 
Media scares related to MMR 
created anxiety whilst community 
insulation from TB created a 
sense of safety with the 
consequence of low BCG uptake.  
Challenge of 
community norms best 
done through existing 
social networks to 
communicate positive 
messages. 
Avoid assumptions 
that religious beliefs 
act as a barrier to 
immunisation uptake.  
Hilton* et al, 
2006a 
Glasgow, 
Scotland 
Focus Groups. 
 
To explore 
parents’ 
understanding of 
immunity. 
Purposive sample. 
Full demography of 
parents (mothers and 
fathers) not given but 
sampling included range 
of ages, socio-economic 
and family characteristics, 
immunisers and non-
immunisers. 
n=72. Concerns about maturity of 
children’s immune systems and 
coping with vaccine overload 
(note many already accepted 
DTP). 
 
If offered choice would go for 
single vaccines 
Immune vulnerability of children 
and MMR added burden 
And/or too healthy to need MMR 
protection. 
 
Risk assessment by parents 
includes (1) risk of disease(s), (2) 
risk from vaccine and (3) parental 
perception of child’s immune 
capacity to cope with disease 
and/or vaccine.  
Need to address gaps 
in understanding of 
child immune systems 
and fears of immune 
overload. 
Note: Hilton et al (2006a, b, & 2007) all relate to the same study but present different thematic analysis of data. 
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Table 7: Qualitative studies included (continued) 
Authors, 
Year, Place, 
Country  
Design / 
Method 
Aim Description of 
Participants 
Sampl
e size 
Results  Recommendations 
Hilton* et al, 
2006b 
Glasgow. 
Scotland  
Focus 
Groups. 
 
To explore 
perceptions 
of vaccine 
preventable 
diseases. 
Purposive 
Full demography of parents 
(mothers and fathers) not 
given but sampling included 
range of ages, socio-
economic and family 
characteristics, immunisers 
and non-immunisers. 
Targeted two high uptake 
areas >95% and two low 
<75%.  
n=72 Supported vaccination against 
Meningococcal meningitis “insist on getting” 
vaccine. 
 
Mumps, measles and rubella not perceived 
as threat and mumps and rubella perceived 
as gender specific problematic conditions 
Efficacy of MMR doubted. 
 
Pentavalent prevented diseases not seen 
as a threat in the UK and knowledge less 
particularly Hib. 
 
Understood tetanus but could get jab if in 
an accident. 
Need to overcome 
misunderstandings 
and gaps in 
knowledge of vaccine 
preventable diseases 
(success of 
immunisation 
programme has 
produced memory 
loss). 
 
Those involved in 
supporting decision-
making need to 
recognise the complex 
role of personal choice 
and family history as 
contributing.  
Hilton* et al, 
2007 
Central 
Scotland. 
Scotland  
Focus 
Groups. 
 
To explored 
nature of 
concerns 
about MMR 
safety. 
Purposive 
n=64 mothers (age range 
15-53 years) and n=8 
fathers (age range 31-51 
years) sampling included 
range of ages, socio-
economic and family 
characteristics, immunisers 
and non-immunisers. 
 
n=72 Evidence from parents who believed MMR 
harmed their children could not be 
discounted. 
 
Parents could assess trustworthiness of 
parents’ stories but not research evidence. 
 
Drawn to real life stories in the media. 
Politicians were untrustworthy sources of 
health information. 
 
Concerns about the objectivity of GPs 
(incentives for immunisation targets) and 
others. HVs could sound too ‘resolute’. 
Wakefield seen as credible and parent 
champion. 
Use of anecdotal 
stories involving real 
people. 
 
Use of parents to 
communicate about 
MMR to the public. 
 
HCPs must a void 
ambiguous messages 
or presenting 
entrenched views. 
 
Note: Hilton et al (2006a, b, & 2007) all relate to the same study but present different thematic analysis of data. 
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Table 7: Qualitative studies included (continued) 
Authors, 
Year, Place, 
Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
McMurray et al, 
2004 
Leeds. 
England  
Qualitative 
interviewing 
and 
‘framework’ 
analysis. 
To explore 
parents’ 
accounts of 
MMR 
decision 
making  
Purposive sample. 
Parents of children aged 
4-5 years 
65 mothers, 4 fathers. 
MMR uptake 75% plus 
18% lost at 2nd dose 
PHC practitioners, co-
ordinators and managers. 
(n=12). 
n=69. Measles, mumps and rubella 
seen as ‘positive’ diseases for 
building immunity. 
 
Vaccination decisions based on 
day to day observation of child 
rather than science. 
Media increased concerns which 
led to parents undertaking 
personal research. 
 
Friends and families shared 
feelings and concerns. 
 
GPs and HVs accessed for 
advice but little influence on 
decision as HCPs perceived as 
too biased. 
GP consultations too rushed for 
discussion. 
No information received prior to 
appointment for 2nd vaccination 
(MMR2) and could not recall 
receiving information for 1st dose. 
 
Official information dull and not 
relevant to real lives. 
 
Attendance at clinic for MMR1 
perceived as informed consent. 
Drop-in sessions and 
forums to discuss 
issues and concerns. 
 
Use of Information 
intermediaries. 
 
Written information 
prior to appointments 
with case studies. 
 
At vaccination 
appointment the 
interaction should be 
two way. 
 
To increase trust in 
MMR remove target 
payments. 
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Table 7: Qualitative studies included (continued) 
Authors, 
Year, Place, 
Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
Mixer et al, 
2007 
Brent, NW 
London. 
England  
Focus Groups. To explore 
relationship 
between 
ethnicity 
and uptake 
of MMR1 
vaccine. 
Convenience sample of 
mothers (Asian [Uptake 
87.1%], Afro-Caribbean 
[74.7%]and white 
[57.5%]. 
n=37. Asian mothers consulted elders 
(mothers in law) for advice and they 
had illness memory and largely pro-
immunisation. 
Asian mothers more likely to trust 
GPs or HVs advice and were 
‘shielded’ from MMR controversy in 
media. 
Trust in HCPs least in white and Afro-
Caribbean mothers as most exposed 
to the English-language media. 
 
Paradoxically in MMR greater 
knowledge more likely to reduce 
compliance. 
No recommendations given. 
Morgan et al , 
2003 
North West 
London, 
England  
Telephone 
interviews. 
To assess 
MMR 
response 
to measles 
outbreak. 
Parents of children 
attending nursery school 
with measles outbreak. 
Not 
given. 
Measles not seen as a serious 
illness. 
Catching measles also seen as 
protection against rubella and 
mumps. 
HCPs were confused by non-
schedule recommendations 
regarding immunisation regime. 
 
Non-schedule advice to GPs 
re: MMR should come with 
rationale and authority. 
 
Petts & 
Neimeyer, 
2004 
West 
Midlands, 
England  
Two phase 
interactive 
discussion 
groups and 
textual data 
analysis. Two 
questionnaires 
administered (i) 
after 1st 
meeting 
children’s 
To explore 
the 
information 
strategies 
parents’ 
use to 
make 
sense of 
health risks 
particularly 
MMR. 
Random on-street 
recruitment by agency. 
89% mothers, 30% from 
Asian Muslim community, 
included immunisers, 
those yet to make the 
decision and fathers.  
n=64. Mixed experience of GPs particularly 
Asian parents felt ignored. 
 
Low exposure to official information, 
high awareness of autism links. 
 
Perception that side effects of 
immunisations unknown. 
 
Heightened awareness if MMR 
challenged convictions about benefits 
Information wanted on risks 
to health, certainty of 
science, balance of risks 
with having/not having 
vaccine. 
 
User centred risk 
communication. 
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immunisation 
history and  
(ii) after 2nd 
interview 
concerning 
MMR 
information 
needs, mode of 
delivery and 
trusted 
sources. 
Participants 
asked to 
undertake 
personal 
research 
between 
meetings and 
could question 
an 
immunisation 
specialist at 2nd 
interview.  
and previous decisions (with other 
children). 
 
Media representation of MMR had 
shaken pre-existing beliefs (including 
Blair’s non response regarding 
immunisation of his son). 
 
Informal MMR talk from friends was 
primary source of information about 
single vaccines. 
 
Parental choice important particularly 
when perceived they were pressured 
by government. 
 
Ranking of trustworthy sources of 
information (questionnaire) not 
consistent with important sources 
identified in interviews. 
 
Full information (expert input part of 
research design) about mumps, 
measles and rubella “compelling”. 
 
Sought information about media 
generated issues from expert and 
these not evident in official leaflets. 
 
Only British mothers with high socio-
economic status reported positive 
engagement with GPs in relation to 
MMR. 
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Table 7: Qualitative studies included (continued) 
Authors, 
Year, Place, 
Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
Poltarak et al, 
2005 
Brighton. 
England  
Ethnographic/bi
ographical 
Face to face in-
depth 
Interviews. 
Group 
discussions 
Work 
shadowing and 
follow up 
interviews with 
HVs (HVs). 
To explore 
how 
parents’ 
were 
thinking 
about 
MMR for 
their own 
children. 
GPs from target practices 
(n=8) 
Practice nurses (n=3) 
HVs (n=6). 
Mothers from local 
toddlers groups 
Immunisers (n=12). 
n=29. Mothers: 
History (immunisation and disease) 
influenced decision-making – notions 
of overload, vulnerability and 
individual immunity. 
Only 4four were confident in MMR 
most were suspicious of Drs, drug 
companies, and pressure to 
immunise. 
Parental choice (link made to birth 
choices and MMR decision). 
Relationship between motherhood 
camaraderie/friendship development 
and ways of discussing MMR. 
Need to do personal research to 
make decision but creates greater 
doubt. 
GPs not consulted and deemed 
partial. 
Mothers perception of being 
patronised/intimidated read as 
acquiescence by GPs. 
Decision to immunise did not resolve 
concerns about MMR. 
Parents learn from 
listening and sharing in 
toddler groups. 
 
Joint parent decision. 
 
Personalised framing 
demands personalised 
approach to immunisation 
and parental decision-
making. 
 
MMR talk may be more 
influential than public 
health information 
therefore need to change 
the messages in the talk. 
 
HCPs need to be in 
dialogue with parents. 
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Table 7: Qualitative studies included (continued) 
Authors, 
Year, Place, 
Country  
Design / 
Method 
Aim Description of 
Participants 
Sample 
size 
Results  Recommendations 
Raithatha et 
al, 2003 
Norwich, 
England  
In-depth 
interviews. 
To assess 
parents’ vaccine 
risk perception. 
Convenience sample. 
Local rate of MMR uptake 
>90%. 
All immunisers 
Two groups (Town & 
Village) 
33 Female, 1 male. 
Mean age 34 years 
Social class I-IV. 
n=35. Parents perceived vaccines as risky 
and doubted the science. 
Felt unfairly pressurised by HCPs to 
vaccinate. 
Lack of information and conflicting 
advice. 
Distrust of government agencies. 
Distrust of GPs (financial incentives). 
Doubts of knowledge base of and 
accuracy of Drs. 
Scandals tarnished image of Drs. 
Consequences of decision to 
immunise were heavy but parents felt 
they would be criticised if their child 
contracted the disease.  
Messages should be 
balanced. 
HCPs must listen to 
concerns. 
GP incentives re-
evaluated. 
Information should be 
locally not nationally 
disseminated . 
Skea et al, 
2008 
Internet 
discussion 
forum. 
(www.mumsn
et.com). 
Thematic 
analysis 
using 
modified 
framework 
analysis. 
To explore 
parents’ 
perceptions of 
public health 
responsibilities 
through MMR. 
Members anonymised 
postings no personal data 
solicited for the study 
Informants largely 
immunisers (n=72). 
n=89. Parents were aware and concerned 
about responsibilities to the wider 
community. 
Avoiding harm to others and 
contributing to herd immunity were 
important considerations. 
Parents balanced probabilities of 
personal concerns for own child with 
responsibility to others. 
Parents differentiated between 
healthy and vulnerable children. 
Parents were expected to act to 
benefit society but felt more should 
be done to compensate those 
harmed by vaccines.  
Vaccine promotional 
material should include 
explanations of herd 
immunity and pay attention 
to lay concepts of 
immunity including 
vulnerable and healthy 
children.  
 
